BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 874676 Cc1cc(ccc1OC1CCc2cccc(c12)-c1cccc(c1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H34F3N3O4/c1-21-18-25(22-14-16-41(17-15-22)34(43)24-8-9-24)11-12-30(21)46-31-13-10-23-4-3-7-28(32(23)31)26-5-2-6-27(19-26)42-33(36(37,38)39)29(20-40-42)35(44)45/h2-7,11-12,18-20,22,24,31H,8-10,13-17H2,1H3,(H,44,45) SCBLGHKVJDNEAE-UHFFFAOYSA-N 430635 US10550102, Example (-)-1. b) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 10.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430635&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627941 438639653 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874677 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C35H37N5O3/c1-21-19-26(23-15-17-39(18-16-23)34(41)25-9-10-25)12-13-29(21)37-31-14-11-24-5-3-6-27(33(24)31)30-7-4-8-32(38-30)40-22(2)28(20-36-40)35(42)43/h3-8,12-13,19-20,23,25,31,37H,9-11,14-18H2,1-2H3,(H,42,43) MAUQVVDVXCBOHQ-UHFFFAOYSA-N 430642 US10550102, Example 7a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430642&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627945 438639657 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874678 Cc1cc(ccc1OC1CCc2cccc(c12)-c1cccc(c1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H34F3N3O4/c1-21-18-25(22-14-16-41(17-15-22)34(43)24-8-9-24)11-12-30(21)46-31-13-10-23-4-3-7-28(32(23)31)26-5-2-6-27(19-26)42-33(36(37,38)39)29(20-40-42)35(44)45/h2-7,11-12,18-20,22,24,31H,8-10,13-17H2,1H3,(H,44,45) SCBLGHKVJDNEAE-UHFFFAOYSA-N 430649 US10550102, Example (+)-1. b) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430649&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627941 438639662 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874679 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C37H41N5O3/c1-4-45-37(44)30-22-38-42(24(30)3)34-10-6-9-32(40-34)29-8-5-7-26-13-16-33(35(26)29)39-31-15-14-28(21-23(31)2)25-17-19-41(20-18-25)36(43)27-11-12-27/h5-10,14-15,21-22,25,27,33,39H,4,11-13,16-20H2,1-3H3 ANFYHALPLAPZDN-UHFFFAOYSA-N 430673 US10550102, Example 7b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430673&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627899 438639680 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874680 Cc1c(cnn1-c1cccc(c1)-c1cccc2CC[C@H](Oc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H37N3O4/c1-22-19-27(24-15-17-38(18-16-24)35(40)26-9-10-26)12-13-32(22)43-33-14-11-25-5-4-8-30(34(25)33)28-6-3-7-29(20-28)39-23(2)31(21-37-39)36(41)42/h3-8,12-13,19-21,24,26,33H,9-11,14-18H2,1-2H3,(H,41,42)/t33-/m0/s1 WISJRAOXBPFAMB-XIFFEERXSA-N 430678 Example 2-A. (+)-(S)-Ethyl-1-(3-(3-(4-(1-(cyclopropanecarbonyl)piperidin-4-yl)-2-methylphenoxy)-2,3-dihydro-1H-inden-4-yl)phenyl)-6-methyl-1H-pyrazole-4-carboxylate::US10550102, Example 2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430678&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628156 438639685 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874681 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C35H34F3N5O3/c1-20-18-24(21-14-16-42(17-15-21)33(44)23-8-9-23)11-12-27(20)40-29-13-10-22-4-2-5-25(31(22)29)28-6-3-7-30(41-28)43-32(35(36,37)38)26(19-39-43)34(45)46/h2-7,11-12,18-19,21,23,29,40H,8-10,13-17H2,1H3,(H,45,46) QNKBXCDMAQJIKJ-UHFFFAOYSA-N 430679 US10550102, Example (-)-8. b) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 53.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430679&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627916 438639686 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874682 Cc1cc(ccc1OC1CCc2cccc(c12)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C35H33F3N4O4/c1-20-18-24(21-14-16-41(17-15-21)33(43)23-8-9-23)11-12-28(20)46-29-13-10-22-4-2-5-25(31(22)29)27-6-3-7-30(40-27)42-32(35(36,37)38)26(19-39-42)34(44)45/h2-7,11-12,18-19,21,23,29H,8-10,13-17H2,1H3,(H,44,45) ZPQUBWSSWCZJJM-UHFFFAOYSA-N 430739 US10550102, Example 3a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430739&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628067 438639746 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874683 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C35H34F3N5O3/c1-20-18-24(21-14-16-42(17-15-21)33(44)23-8-9-23)11-12-27(20)40-29-13-10-22-4-2-5-25(31(22)29)28-6-3-7-30(41-28)43-32(35(36,37)38)26(19-39-43)34(45)46/h2-7,11-12,18-19,21,23,29,40H,8-10,13-17H2,1H3,(H,45,46) QNKBXCDMAQJIKJ-UHFFFAOYSA-N 430740 US10550102, Example (+)-8. b) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430740&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627916 438639747 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874684 CCOC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCC(Oc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C37H37F3N4O4/c1-3-47-36(46)28-21-41-44(34(28)37(38,39)40)32-9-5-8-29(42-32)27-7-4-6-24-12-15-31(33(24)27)48-30-14-13-26(20-22(30)2)23-16-18-43(19-17-23)35(45)25-10-11-25/h4-9,13-14,20-21,23,25,31H,3,10-12,15-19H2,1-2H3 JCDHXZLCXOEAIM-UHFFFAOYSA-N 430859 US10550102, Example 3b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 6.90 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430859&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628068 438639864 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874685 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C34H35N5O3/c1-21-28(34(41)42)20-35-39(21)31-7-3-6-29(37-31)27-5-2-4-24-12-15-30(32(24)27)36-26-13-10-22(11-14-26)23-16-18-38(19-17-23)33(40)25-8-9-25/h2-7,10-11,13-14,20,23,25,30,36H,8-9,12,15-19H2,1H3,(H,41,42) KMZIJZGAFPSODO-UHFFFAOYSA-N 430860 US10550102, Example 9. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 184 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430860&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627933 438639865 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874686 OC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCC(Oc3ccc4CN(Cc5ccccn5)CCc4c3)c12 InChI=1S/C34H28F3N5O3/c35-34(36,37)32-27(33(43)44)18-39-42(32)30-9-4-8-28(40-30)26-7-3-5-21-11-13-29(31(21)26)45-25-12-10-23-19-41(16-14-22(23)17-25)20-24-6-1-2-15-38-24/h1-10,12,15,17-18,29H,11,13-14,16,19-20H2,(H,43,44) DYDRUUIDSBBBCY-UHFFFAOYSA-N 430861 US10550102, Example 4a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430861&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628084 438639866 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874687 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C34H35N5O3/c1-21-28(34(41)42)20-35-39(21)31-7-3-6-29(37-31)27-5-2-4-24-12-15-30(32(24)27)36-26-13-10-22(11-14-26)23-16-18-38(19-17-23)33(40)25-8-9-25/h2-7,10-11,13-14,20,23,25,30,36H,8-9,12,15-19H2,1H3,(H,41,42) KMZIJZGAFPSODO-UHFFFAOYSA-N 430862 US10550102, Example 9. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430862&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627933 438639867 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874688 CCOC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCC(Oc3ccc4CN(Cc5ccccn5)CCc4c3)c12 InChI=1S/C36H32F3N5O3/c1-2-46-35(45)29-20-41-44(34(29)36(37,38)39)32-11-6-10-30(42-32)28-9-5-7-23-13-15-31(33(23)28)47-27-14-12-25-21-43(18-16-24(25)19-27)22-26-8-3-4-17-40-26/h3-12,14,17,19-20,31H,2,13,15-16,18,21-22H2,1H3 TVMPJAVDMDUABN-UHFFFAOYSA-N 430863 US10550102, Example 4b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 116 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430863&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199985 438639868 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874689 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H39N5O3/c1-3-32-28(36(43)44)21-37-41(32)33-9-5-8-30(39-33)27-7-4-6-24-12-15-31(34(24)27)38-29-14-13-26(20-22(29)2)23-16-18-40(19-17-23)35(42)25-10-11-25/h4-9,13-14,20-21,23,25,31,38H,3,10-12,15-19H2,1-2H3,(H,43,44) CDKSIEFPZCBKLU-UHFFFAOYSA-N 430864 US10550102, Example 10a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430864&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628009 438639869 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874690 Cc1cc2CCC(Oc3ccc4CN(Cc5ccccn5)CCc4c3)c2c(c1)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F InChI=1S/C35H30F3N5O3/c1-21-15-23-9-11-30(46-26-10-8-24-19-42(14-12-22(24)17-26)20-25-5-2-3-13-39-25)32(23)27(16-21)29-6-4-7-31(41-29)43-33(35(36,37)38)28(18-40-43)34(44)45/h2-8,10,13,15-18,30H,9,11-12,14,19-20H2,1H3,(H,44,45) CMOKNYBSBSDAJV-UHFFFAOYSA-N 430865 US10550102, Example 5-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 39.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430865&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199865 438639870 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874691 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C38H43N5O3/c1-4-34-30(38(45)46-5-2)23-39-43(34)35-11-7-10-32(41-35)29-9-6-8-26-14-17-33(36(26)29)40-31-16-15-28(22-24(31)3)25-18-20-42(21-19-25)37(44)27-12-13-27/h6-11,15-16,22-23,25,27,33,40H,4-5,12-14,17-21H2,1-3H3 FBLLIFABVUGMPF-UHFFFAOYSA-N 430866 US10550102, Example 10b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 49.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430866&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627928 438639871 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874692 Cc1cc2CCC(Oc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c2c(c1)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F InChI=1S/C36H35F3N4O4/c1-20-16-25-9-11-30(47-29-10-8-24(18-21(29)2)22-12-14-42(15-13-22)34(44)23-6-7-23)32(25)26(17-20)28-4-3-5-31(41-28)43-33(36(37,38)39)27(19-40-43)35(45)46/h3-5,8,10,16-19,22-23,30H,6-7,9,11-15H2,1-2H3,(H,45,46) RMVACRSUFBQBAE-UHFFFAOYSA-N 430867 US10550102, Example 5-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430867&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199916 438639872 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874693 Cc1cc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c2c(c1)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F InChI=1S/C36H36F3N5O3/c1-20-16-25-9-11-30(41-28-10-8-24(18-21(28)2)22-12-14-43(15-13-22)34(45)23-6-7-23)32(25)26(17-20)29-4-3-5-31(42-29)44-33(36(37,38)39)27(19-40-44)35(46)47/h3-5,8,10,16-19,22-23,30,41H,6-7,9,11-15H2,1-2H3,(H,46,47) ODHZMNOWYDDYOX-UHFFFAOYSA-N 430868 US10550102, Example 11-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430868&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627970 438639873 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874694 CCc1cc(O[C@H]2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C(F)(F)F)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H35F3N4O4/c1-2-21-19-25(12-13-26(21)22-15-17-42(18-16-22)34(44)24-9-10-24)47-30-14-11-23-5-3-6-27(32(23)30)29-7-4-8-31(41-29)43-33(36(37,38)39)28(20-40-43)35(45)46/h3-8,12-13,19-20,22,24,30H,2,9-11,14-18H2,1H3,(H,45,46)/t30-/m0/s1 HMQMEEGPBGWFQL-PMERELPUSA-N 430869 US10550102, Example 5-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430869&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628059 438639874 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874695 OC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C34H32F3N5O3/c35-34(36,37)31-26(33(44)45)19-38-42(31)29-6-2-5-27(40-29)25-4-1-3-22-11-14-28(30(22)25)39-24-12-9-20(10-13-24)21-15-17-41(18-16-21)32(43)23-7-8-23/h1-6,9-10,12-13,19,21,23,28,39H,7-8,11,14-18H2,(H,44,45) HUGMXQQOSVJRAB-UHFFFAOYSA-N 430870 US10550102, Example 11-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430870&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199978 438639875 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874696 Cc1cc(ccc1O[C@H]1CCc2cccc(c12)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC(F)(F)F)CC1 InChI=1S/C33H30F6N4O3/c1-19-16-22(20-12-14-42(15-13-20)18-32(34,35)36)9-10-26(19)46-27-11-8-21-4-2-5-23(29(21)27)25-6-3-7-28(41-25)43-30(33(37,38)39)24(17-40-43)31(44)45/h2-7,9-10,16-17,20,27H,8,11-15,18H2,1H3,(H,44,45)/t27-/m0/s1 COIUJLKQOATJCQ-MHZLTWQESA-N 430871 US10550102, Example 5-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430871&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130200004 438639876 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874697 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC(F)(F)F)CC3)c12)C(O)=O InChI=1S/C34H36F3N5O2/c1-3-30-26(33(43)44)19-38-42(30)31-9-5-8-28(40-31)25-7-4-6-23-10-13-29(32(23)25)39-27-12-11-24(18-21(27)2)22-14-16-41(17-15-22)20-34(35,36)37/h4-9,11-12,18-19,22,29,39H,3,10,13-17,20H2,1-2H3,(H,43,44) JWOWGMROKBROJQ-UHFFFAOYSA-N 430872 US10550102, Example 11-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430872&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199956 438639877 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874698 Cc1cc(ccc1O[C@H]1CCc2cccc(c12)-c1cccc(n1)-n1cc(cn1)C(O)=O)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C34H34N4O4/c1-21-18-25(22-14-16-37(17-15-22)33(39)24-8-9-24)11-12-29(21)42-30-13-10-23-4-2-5-27(32(23)30)28-6-3-7-31(36-28)38-20-26(19-35-38)34(40)41/h2-7,11-12,18-20,22,24,30H,8-10,13-17H2,1H3,(H,40,41)/t30-/m0/s1 XGYXNFPCRQWESI-PMERELPUSA-N 430873 US10550102, Example 5-5 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430873&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199856 438639878 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874699 Cc1c(cnn1-c1cccc(c1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H38N4O3/c1-22-19-27(24-15-17-39(18-16-24)35(41)26-9-10-26)12-13-32(22)38-33-14-11-25-5-4-8-30(34(25)33)28-6-3-7-29(20-28)40-23(2)31(21-37-40)36(42)43/h3-8,12-13,19-21,24,26,33,38H,9-11,14-18H2,1-2H3,(H,42,43) MZMWWWTUEBKUJA-UHFFFAOYSA-N 430874 US10550102, Example 11-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430874&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627950 438639879 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874700 Cc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C35H36N4O4/c1-21-19-26(23-15-17-38(18-16-23)34(40)25-9-10-25)12-13-30(21)43-31-14-11-24-5-3-6-27(33(24)31)29-7-4-8-32(37-29)39-22(2)28(20-36-39)35(41)42/h3-8,12-13,19-20,23,25,31H,9-11,14-18H2,1-2H3,(H,41,42)/t31-/m0/s1 XPHLKLQXCZUOPG-HKBQPEDESA-N 430875 US10550102, Example 5-6 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430875&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199957 438639880 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874701 CCOC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCN(Cc3ccc(cc3)C3CCN(CC3)C(=O)OC(C)(C)C)c12 InChI=1S/C37H40F3N5O4/c1-5-48-34(46)29-22-41-45(33(29)37(38,39)40)31-11-7-10-30(42-31)28-9-6-8-27-18-21-44(32(27)28)23-24-12-14-25(15-13-24)26-16-19-43(20-17-26)35(47)49-36(2,3)4/h6-15,22,26H,5,16-21,23H2,1-4H3 QLTPBIHGEKOHBE-UHFFFAOYSA-N 430876 Example 12-A. tert-Butyl 4-(4-((7-(6-(4-(ethoxycarbonyl)-6-(trifluoromethyl)-1H-pyrazol-1-yl)pyridin-2-yl)indolin-1-yl)methyl)phenyl)piperidine-1-carboxylate::US10550102, Example 12 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430876&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211485 438639881 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874702 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H38N4O4/c1-3-30-28(36(42)43)21-37-40(30)33-9-5-8-29(38-33)27-7-4-6-24-12-15-32(34(24)27)44-31-14-13-26(20-22(31)2)23-16-18-39(19-17-23)35(41)25-10-11-25/h4-9,13-14,20-21,23,25,32H,3,10-12,15-19H2,1-2H3,(H,42,43)/t32-/m0/s1 NCRQOOBGNGBFFE-YTTGMZPUSA-N 430877 US10550102, Example 5-7 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430877&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199876 438639882 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874703 CCOC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCN(Cc3ccc(C4CCN(CC4)C(=O)OC(C)(C)C)c(CC)c3)c12 InChI=1S/C39H44F3N5O4/c1-6-26-22-25(14-15-29(26)27-16-19-45(20-17-27)37(49)51-38(3,4)5)24-46-21-18-28-10-8-11-30(34(28)46)32-12-9-13-33(44-32)47-35(39(40,41)42)31(23-43-47)36(48)50-7-2/h8-15,22-23,27H,6-7,16-21,24H2,1-5H3 NJGYDCIQCKOCLT-UHFFFAOYSA-N 430878 Example 13-A. tert-Butyl 4-(4-((7-(6-(4-(ethoxycarbonyl)-6-(trifluoromethyl)-1H-pyrazol-1-yl)pyridin-2-yl)indolin-1-yl)methyl)-2-ethylphenyl)piperidine-1-carboxylate::US10550102, Example 13 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430878&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211486 438639883 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874704 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(cc3C)C3CCN(CC(F)(F)F)CC3)c12)C(O)=O InChI=1S/C34H35F3N4O3/c1-3-28-26(33(42)43)19-38-41(28)31-9-5-8-27(39-31)25-7-4-6-23-10-13-30(32(23)25)44-29-12-11-24(18-21(29)2)22-14-16-40(17-15-22)20-34(35,36)37/h4-9,11-12,18-19,22,30H,3,10,13-17,20H2,1-2H3,(H,42,43)/t30-/m0/s1 JINXIMYMACLTRI-PMERELPUSA-N 430879 US10550102, Example 5-8 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430879&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199886 438639884 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874705 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCN(Cc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C37H41N5O3/c1-3-25-21-24(11-14-29(25)26-15-18-40(19-16-26)36(43)28-12-13-28)23-41-20-17-27-7-5-8-30(35(27)41)32-9-6-10-34(39-32)42-33(4-2)31(22-38-42)37(44)45/h5-11,14,21-22,26,28H,3-4,12-13,15-20,23H2,1-2H3,(H,44,45) HAMFJJDEDZILSJ-UHFFFAOYSA-N 430880 Example 14-A. tert-Butyl 4-(4-((7-(6-(4-(ethoxycarbonyl)-5-ethyl)-1H-pyrazol-1-yl)pyridin-2-yl)indolin-1-yl)methyl)-2-ethylphenyl)piperidine-1-carboxylate::US10550102, Example 14 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430880&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627913 438639885 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874706 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C37H40N4O4/c1-3-23-21-27(14-15-28(23)24-17-19-40(20-18-24)36(42)26-11-12-26)45-33-16-13-25-7-5-8-29(35(25)33)31-9-6-10-34(39-31)41-32(4-2)30(22-38-41)37(43)44/h5-10,14-15,21-22,24,26,33H,3-4,11-13,16-20H2,1-2H3,(H,43,44)/t33-/m0/s1 CFODZFQAKYNIQQ-XIFFEERXSA-N 430881 US10550102, Example 5-9 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430881&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199994 438639886 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874707 CCc1cc(CN2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C(F)(F)F)ccc1C1CCN(CC(F)(F)F)CC1 InChI=1S/C34H33F6N5O2/c1-2-22-17-21(9-10-25(22)23-11-14-43(15-12-23)20-33(35,36)37)19-44-16-13-24-5-3-6-26(30(24)44)28-7-4-8-29(42-28)45-31(34(38,39)40)27(18-41-45)32(46)47/h3-10,17-18,23H,2,11-16,19-20H2,1H3,(H,46,47) DHAAPVCRDKCLSI-UHFFFAOYSA-N 430882 Example 15-A. Ethyl 1-(6-(1-(3-ethyl-4-1-(2,2,2-trifluoroethyl)piperidin-4-yl)benzyl)indolin-7-yl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate::US10550102, Example 15 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.50 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430882&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628094 438639887 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874708 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(c1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H35F3N4O3/c1-21-18-25(22-14-16-42(17-15-22)34(44)24-8-9-24)11-12-30(21)41-31-13-10-23-4-3-7-28(32(23)31)26-5-2-6-27(19-26)43-33(36(37,38)39)29(20-40-43)35(45)46/h2-7,11-12,18-20,22,24,31,41H,8-10,13-17H2,1H3,(H,45,46) UJPZBWRMNIMCKD-UHFFFAOYSA-N 430883 US10550102, Example 6. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430883&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627954 438639888 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874709 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2CCN(Cc3ccc(C4CCN(CC(F)(F)F)CC4)c(CC)c3)c12 InChI=1S/C37H42F3N5O2/c1-4-26-21-25(13-14-29(26)27-15-18-43(19-16-27)24-37(38,39)40)23-44-20-17-28-9-7-10-30(35(28)44)32-11-8-12-34(42-32)45-33(5-2)31(22-41-45)36(46)47-6-3/h7-14,21-22,27H,4-6,15-20,23-24H2,1-3H3 VVRSJVDBZPGFOY-UHFFFAOYSA-N 430884 Example 16-A. Ethyl 5-ethyl-1-(6-(1-(3-ethyl-4-(2,2,22-trifluoroethyl)piperidin-4-yl)benzyl)indolin-7-yl)pyridin-2-yl)-1H-pyrazole-4-carboxylate::US10550102, Example 16 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.50 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430884&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628006 438639889 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874710 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(c1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H35F3N4O3/c1-21-18-25(22-14-16-42(17-15-22)34(44)24-8-9-24)11-12-30(21)41-31-13-10-23-4-3-7-28(32(23)31)26-5-2-6-27(19-26)43-33(36(37,38)39)29(20-40-43)35(45)46/h2-7,11-12,18-20,22,24,31,41H,8-10,13-17H2,1H3,(H,45,46) UJPZBWRMNIMCKD-UHFFFAOYSA-N 430885 US10550102, Example 6. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 24.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430885&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627954 438639890 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874711 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CCC3)c12)C(O)=O InChI=1S/C36H39N5O3/c1-22-20-27(24-16-18-40(19-17-24)35(42)26-7-3-8-26)13-14-30(22)38-32-15-12-25-6-4-9-28(34(25)32)31-10-5-11-33(39-31)41-23(2)29(21-37-41)36(43)44/h4-6,9-11,13-14,20-21,24,26,32,38H,3,7-8,12,15-19H2,1-2H3,(H,43,44) ZTQJXWLAWUUEAH-UHFFFAOYSA-N 430886 US10550102, Example 45a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430886&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628003 438639891 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874712 CCc1cc(O[C@H]2CCc3cccc(c23)-c2cccc(n2)-n2ccc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C37H39N3O4/c1-3-24-22-28(13-14-30(24)25-16-19-39(20-17-25)36(41)27-10-11-27)44-33-15-12-26-6-4-7-31(35(26)33)32-8-5-9-34(38-32)40-21-18-29(23(40)2)37(42)43/h4-9,13-14,18,21-22,25,27,33H,3,10-12,15-17,19-20H2,1-2H3,(H,42,43)/t33-/m0/s1 XJAGLUYEWGGHME-XIFFEERXSA-N 430887 US10550102, Example 5-10 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430887&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 138569748 438639892 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874713 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)OC(C)(C)C)c12 InChI=1S/C38H45N5O4/c1-7-46-36(44)30-23-39-43(25(30)3)34-13-9-12-32(41-34)29-11-8-10-27-14-17-33(35(27)29)40-31-16-15-28(22-24(31)2)26-18-20-42(21-19-26)37(45)47-38(4,5)6/h8-13,15-16,22-23,26,33,40H,7,14,17-21H2,1-6H3 GICHLMDIOIFJEH-UHFFFAOYSA-N 430888 US10550102, Example 45b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.50 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430888&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211502 438639893 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874714 CCc1c(cnn1-c1cccc(n1)-c1cccc2C(C)CN(Cc3ccc(C4CCN(CC4)C(=O)[C@H](C)O)c(CC)c3)c12)C(O)=O InChI=1S/C37H43N5O4/c1-5-26-19-25(13-14-29(26)27-15-17-40(18-16-27)36(44)24(4)43)22-41-21-23(3)28-9-7-10-30(35(28)41)32-11-8-12-34(39-32)42-33(6-2)31(20-38-42)37(45)46/h7-14,19-20,23-24,27,43H,5-6,15-18,21-22H2,1-4H3,(H,45,46)/t23?,24-/m0/s1 YUGYFCOSKDDEIM-CGAIIQECSA-N 430889 US10550102, Example 17a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430889&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627987 438639894 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874715 CC(C)C(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C35H39N5O3/c1-21(2)34(41)39-17-15-24(16-18-39)26-12-13-29(22(3)19-26)37-31-14-11-25-7-5-8-27(33(25)31)30-9-6-10-32(38-30)40-23(4)28(20-36-40)35(42)43/h5-10,12-13,19-21,24,31,37H,11,14-18H2,1-4H3,(H,42,43) VRPBEWBDCORIEO-UHFFFAOYSA-N 430890 US10550102, Example (+)-46-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430890&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627980 438639895 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874716 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2c(C)c[nH]c12 InChI=1S/C22H22N4O2/c1-4-19-17(22(27)28-5-2)13-24-26(19)20-11-7-10-18(25-20)16-9-6-8-15-14(3)12-23-21(15)16/h6-13,23H,4-5H2,1-3H3 RWUWPTOBELWEKL-UHFFFAOYSA-N 430891 US10550102, Example 17b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430891&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627940 438639896 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874717 CC(C)C(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C35H39N5O3/c1-21(2)34(41)39-17-15-24(16-18-39)26-12-13-29(22(3)19-26)37-31-14-11-25-7-5-8-27(33(25)31)30-9-6-10-32(38-30)40-23(4)28(20-36-40)35(42)43/h5-10,12-13,19-21,24,31,37H,11,14-18H2,1-4H3,(H,42,43) VRPBEWBDCORIEO-UHFFFAOYSA-N 430892 US10550102, Example (-)-46-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 100.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430892&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627980 438639897 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874718 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCN(Cc3ccc(cc3C)C3CCN(CC3)C(=O)[C@H](C)O)c12)C(O)=O InChI=1S/C35H39N5O4/c1-4-31-29(35(43)44)20-36-40(31)32-10-6-9-30(37-32)28-8-5-7-25-15-18-39(33(25)28)21-27-12-11-26(19-22(27)2)24-13-16-38(17-14-24)34(42)23(3)41/h5-12,19-20,23-24,41H,4,13-18,21H2,1-3H3,(H,43,44)/t23-/m0/s1 AFVFPZHPDMHXET-QHCPKHFHSA-N 430893 US10550102, Example 18 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430893&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628100 438639898 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874719 CCC(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C34H37N5O3/c1-4-32(40)38-17-15-23(16-18-38)25-12-13-28(21(2)19-25)36-30-14-11-24-7-5-8-26(33(24)30)29-9-6-10-31(37-29)39-22(3)27(20-35-39)34(41)42/h5-10,12-13,19-20,23,30,36H,4,11,14-18H2,1-3H3,(H,41,42) KHMLYZBJCOVAOY-UHFFFAOYSA-N 430894 US10550102, Example (+)-46-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430894&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628057 438639899 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874720 CCc1cc(CN2CC(C)c3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C(F)(F)F)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C37H38F3N5O3/c1-3-24-18-23(10-13-28(24)25-14-16-43(17-15-25)35(46)26-11-12-26)21-44-20-22(2)27-6-4-7-29(33(27)44)31-8-5-9-32(42-31)45-34(37(38,39)40)30(19-41-45)36(47)48/h4-10,13,18-19,22,25-26H,3,11-12,14-17,20-21H2,1-2H3,(H,47,48) AFVAMBIGMGUWON-UHFFFAOYSA-N 430895 US10550102, Example 19a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430895&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628002 438639900 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874721 CCC(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C34H37N5O3/c1-4-32(40)38-17-15-23(16-18-38)25-12-13-28(21(2)19-25)36-30-14-11-24-7-5-8-26(33(24)30)29-9-6-10-31(37-29)39-22(3)27(20-35-39)34(41)42/h5-10,12-13,19-20,23,30,36H,4,11,14-18H2,1-3H3,(H,41,42) KHMLYZBJCOVAOY-UHFFFAOYSA-N 430896 US10550102, Example (-)-46-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 160 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430896&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628057 438639901 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874722 CCOC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2c(C)c[nH]c12 InChI=1S/C21H17F3N4O2/c1-3-30-20(29)15-11-26-28(19(15)21(22,23)24)17-9-5-8-16(27-17)14-7-4-6-13-12(2)10-25-18(13)14/h4-11,25H,3H2,1-2H3 UDUIGYYUJWKSGX-UHFFFAOYSA-N 430897 US10550102, Example 19b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430897&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627936 438639902 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874723 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)CC3CC3)c12)C(O)=O InChI=1S/C36H39N5O3/c1-22-19-27(25-15-17-40(18-16-25)34(42)20-24-9-10-24)12-13-30(22)38-32-14-11-26-5-3-6-28(35(26)32)31-7-4-8-33(39-31)41-23(2)29(21-37-41)36(43)44/h3-8,12-13,19,21,24-25,32,38H,9-11,14-18,20H2,1-2H3,(H,43,44) RYBQXHQBIFKCHN-UHFFFAOYSA-N 430898 US10550102, Example (+)-46-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430898&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627979 438639903 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874724 CCc1c(cnn1-c1cccc(n1)-c1cccc2C(C)CN(Cc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H43N5O3/c1-4-26-20-25(12-15-30(26)27-16-18-41(19-17-27)37(44)28-13-14-28)23-42-22-24(3)29-8-6-9-31(36(29)42)33-10-7-11-35(40-33)43-34(5-2)32(21-39-43)38(45)46/h6-12,15,20-21,24,27-28H,4-5,13-14,16-19,22-23H2,1-3H3,(H,45,46) MPYKRBJJKMLRCU-UHFFFAOYSA-N 430899 US10550102, Example (+)-20-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430899&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627997 438639904 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874725 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)CC3CC3)c12)C(O)=O InChI=1S/C36H39N5O3/c1-22-19-27(25-15-17-40(18-16-25)34(42)20-24-9-10-24)12-13-30(22)38-32-14-11-26-5-3-6-28(35(26)32)31-7-4-8-33(39-31)41-23(2)29(21-37-41)36(43)44/h3-8,12-13,19,21,24-25,32,38H,9-11,14-18,20H2,1-2H3,(H,43,44) RYBQXHQBIFKCHN-UHFFFAOYSA-N 430900 US10550102, Example (-)-46-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 303 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430900&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627979 438639905 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874726 CCc1c(cnn1-c1cccc(n1)-c1cccc2C(C)CN(Cc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H43N5O3/c1-4-26-20-25(12-15-30(26)27-16-18-41(19-17-27)37(44)28-13-14-28)23-42-22-24(3)29-8-6-9-31(36(29)42)33-10-7-11-35(40-33)43-34(5-2)32(21-39-43)38(45)46/h6-12,15,20-21,24,27-28H,4-5,13-14,16-19,22-23H2,1-3H3,(H,45,46) MPYKRBJJKMLRCU-UHFFFAOYSA-N 430901 US10550102, Example (-)-20-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430901&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627997 438639906 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874727 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)CC4CC4)c(F)c3C)c12)C(O)=O InChI=1S/C36H38FN5O3/c1-21-29(14-12-26(35(21)37)24-15-17-41(18-16-24)33(43)19-23-9-10-23)39-31-13-11-25-5-3-6-27(34(25)31)30-7-4-8-32(40-30)42-22(2)28(20-38-42)36(44)45/h3-8,12,14,20,23-24,31,39H,9-11,13,15-19H2,1-2H3,(H,44,45) DHGAHHNCUJISSK-UHFFFAOYSA-N 430902 US10550102, Example (+) or (-)-46-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430902&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627999 438639907 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874728 CCc1c(cnn1-c1cccc(n1)-c1cccc2C(C)CN(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C37H41N5O3/c1-4-33-31(37(44)45)20-38-42(33)34-10-6-9-32(39-34)30-8-5-7-29-24(3)21-41(35(29)30)22-28-14-13-27(19-23(28)2)25-15-17-40(18-16-25)36(43)26-11-12-26/h5-10,13-14,19-20,24-26H,4,11-12,15-18,21-22H2,1-3H3,(H,44,45) IVMOVZQPBCXSMH-UHFFFAOYSA-N 430903 US10550102, Example (+)-20-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 9.90 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430903&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628075 438639908 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874729 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)CC4CC4)c(F)c3C)c12)C(O)=O InChI=1S/C36H38FN5O3/c1-21-29(14-12-26(35(21)37)24-15-17-41(18-16-24)33(43)19-23-9-10-23)39-31-13-11-25-5-3-6-27(34(25)31)30-7-4-8-32(40-30)42-22(2)28(20-38-42)36(44)45/h3-8,12,14,20,23-24,31,39H,9-11,13,15-19H2,1-2H3,(H,44,45) DHGAHHNCUJISSK-UHFFFAOYSA-N 430904 US10550102, Example (-) or (+)-46-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 136 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430904&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627999 438639909 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874730 CCc1c(cnn1-c1cccc(n1)-c1cccc2C(C)CN(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C37H41N5O3/c1-4-33-31(37(44)45)20-38-42(33)34-10-6-9-32(39-34)30-8-5-7-29-24(3)21-41(35(29)30)22-28-14-13-27(19-23(28)2)25-15-17-40(18-16-25)36(43)26-11-12-26/h5-10,13-14,19-20,24-26H,4,11-12,15-18,21-22H2,1-3H3,(H,44,45) IVMOVZQPBCXSMH-UHFFFAOYSA-N 430905 US10550102, Example (-)-20-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430905&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628075 438639910 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874731 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3cc(F)c(cc3C)C3CCN(CC3)C(=O)CC3CC3)c12)C(O)=O InChI=1S/C36H38FN5O3/c1-21-17-27(24-13-15-41(16-14-24)34(43)18-23-9-10-23)29(37)19-32(21)39-31-12-11-25-5-3-6-26(35(25)31)30-7-4-8-33(40-30)42-22(2)28(20-38-42)36(44)45/h3-8,17,19-20,23-24,31,39H,9-16,18H2,1-2H3,(H,44,45) JHQCMVAMKBIWQZ-UHFFFAOYSA-N 430906 US10550102, Example (+)-46-5 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430906&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627977 438639911 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874732 CCc1cc(CN2CC(C)c3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C37H41N5O3/c1-4-26-19-25(11-14-30(26)27-15-17-40(18-16-27)36(43)28-12-13-28)22-41-21-23(2)29-7-5-8-31(35(29)41)33-9-6-10-34(39-33)42-24(3)32(20-38-42)37(44)45/h5-11,14,19-20,23,27-28H,4,12-13,15-18,21-22H2,1-3H3,(H,44,45) NWALFBTUCMMLOY-UHFFFAOYSA-N 430907 US10550102, Example (+)-20-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430907&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627908 438639912 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874733 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3cc(F)c(cc3C)C3CCN(CC3)C(=O)CC3CC3)c12)C(O)=O InChI=1S/C36H38FN5O3/c1-21-17-27(24-13-15-41(16-14-24)34(43)18-23-9-10-23)29(37)19-32(21)39-31-12-11-25-5-3-6-26(35(25)31)30-7-4-8-33(40-30)42-22(2)28(20-38-42)36(44)45/h3-8,17,19-20,23-24,31,39H,9-16,18H2,1-2H3,(H,44,45) JHQCMVAMKBIWQZ-UHFFFAOYSA-N 430908 US10550102, Example (-)-46-5 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 681 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430908&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627977 438639913 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874734 CCc1cc(CN2CC(C)c3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C37H41N5O3/c1-4-26-19-25(11-14-30(26)27-15-17-40(18-16-27)36(43)28-12-13-28)22-41-21-23(2)29-7-5-8-31(35(29)41)33-9-6-10-34(39-33)42-24(3)32(20-38-42)37(44)45/h5-11,14,19-20,23,27-28H,4,12-13,15-18,21-22H2,1-3H3,(H,44,45) NWALFBTUCMMLOY-UHFFFAOYSA-N 430909 US10550102, Example (-)-20-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430909&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627908 438639914 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874735 CCc1cc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H39N5O3/c1-3-23-20-27(13-14-28(23)24-16-18-40(19-17-24)35(42)26-10-11-26)38-32-15-12-25-6-4-7-29(34(25)32)31-8-5-9-33(39-31)41-22(2)30(21-37-41)36(43)44/h4-9,13-14,20-21,24,26,32,38H,3,10-12,15-19H2,1-2H3,(H,43,44) AIGJNNCFPDEVJL-UHFFFAOYSA-N 430910 US10550102, Example (+)-46-6 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430910&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627953 438639915 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874736 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCN(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H39N5O3/c1-3-32-30(36(43)44)21-37-41(32)33-9-5-8-31(38-33)29-7-4-6-25-16-19-40(34(25)29)22-28-13-12-27(20-23(28)2)24-14-17-39(18-15-24)35(42)26-10-11-26/h4-9,12-13,20-21,24,26H,3,10-11,14-19,22H2,1-2H3,(H,43,44) LEBQSYGJWOFCOK-UHFFFAOYSA-N 430911 US10550102, Example 21-1::US10550102, Example 21-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430911&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199875 438639916 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874737 C[C@H](O)C(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C34H37N5O4/c1-20-18-25(23-14-16-38(17-15-23)33(41)22(3)40)11-12-28(20)36-30-13-10-24-6-4-7-26(32(24)30)29-8-5-9-31(37-29)39-21(2)27(19-35-39)34(42)43/h4-9,11-12,18-19,22-23,30,36,40H,10,13-17H2,1-3H3,(H,42,43)/t22-,30?/m0/s1 IEOLUGJOEBKNPV-VUUJKMBOSA-N 430912 US10550102, Example 47a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430912&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627929 438639917 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874738 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCN(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H39N5O3/c1-3-32-30(36(43)44)21-37-41(32)33-9-5-8-31(38-33)29-7-4-6-25-16-19-40(34(25)29)22-28-13-12-27(20-23(28)2)24-14-17-39(18-15-24)35(42)26-10-11-26/h4-9,12-13,20-21,24,26H,3,10-11,14-19,22H2,1-2H3,(H,43,44) LEBQSYGJWOFCOK-UHFFFAOYSA-N 430911 US10550102, Example 21-1::US10550102, Example 21-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430911&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199875 438639916 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874739 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)[C@H](C)O)c12 InChI=1S/C36H41N5O4/c1-5-45-36(44)29-21-37-41(23(29)3)33-11-7-10-31(39-33)28-9-6-8-26-12-15-32(34(26)28)38-30-14-13-27(20-22(30)2)25-16-18-40(19-17-25)35(43)24(4)42/h6-11,13-14,20-21,24-25,32,38,42H,5,12,15-19H2,1-4H3/t24-,32?/m0/s1 HQUFOKJUGCOTOF-RUBXLXHKSA-N 430914 US10550102, Example 47b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 27.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430914&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628025 438639918 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874740 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC(C)N(Cc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H43N5O3/c1-4-26-21-25(12-15-30(26)27-16-18-41(19-17-27)37(44)28-13-14-28)23-42-24(3)20-29-8-6-9-31(36(29)42)33-10-7-11-35(40-33)43-34(5-2)32(22-39-43)38(45)46/h6-12,15,21-22,24,27-28H,4-5,13-14,16-20,23H2,1-3H3,(H,45,46) FYBIOCAIKJADTD-UHFFFAOYSA-N 430915 US10550102, Example 22a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430915&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628043 438639919 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874741 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)[C@H](C)O)c(CC)c3)c12)C(O)=O InChI=1S/C36H41N5O4/c1-4-23-20-26(13-14-27(23)24-16-18-40(19-17-24)35(43)22(3)42)38-31-15-12-25-8-6-9-28(34(25)31)30-10-7-11-33(39-30)41-32(5-2)29(21-37-41)36(44)45/h6-11,13-14,20-22,24,31,38,42H,4-5,12,15-19H2,1-3H3,(H,44,45)/t22-,31?/m0/s1 KEDZLBCTBAXDQH-DEUJGTPJSA-N 430916 US10550102, Example 48a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430916&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628130 438639920 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874742 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2CC(C)Nc12 InChI=1S/C22H24N4O2/c1-4-19-17(22(27)28-5-2)13-23-26(19)20-11-7-10-18(25-20)16-9-6-8-15-12-14(3)24-21(15)16/h6-11,13-14,24H,4-5,12H2,1-3H3 SISJOFILSYHKFK-UHFFFAOYSA-N 430917 US10550102, Example 22b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 4.50 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430917&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628049 438639921 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874743 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCNCC4)c(CC)c3)c12 InChI=1S/C35H41N5O2/c1-4-23-21-26(14-15-27(23)24-17-19-36-20-18-24)38-31-16-13-25-9-7-10-28(34(25)31)30-11-8-12-33(39-30)40-32(5-2)29(22-37-40)35(41)42-6-3/h7-12,14-15,21-22,24,31,36,38H,4-6,13,16-20H2,1-3H3 NUOQCIRFGHHKHX-UHFFFAOYSA-N 430918 US10550102, Example 48b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 11.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430918&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211503 438639922 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874744 CCc1c(cnn1-c1cccc(n1)-c1cccc2c1N(Cc1ccc(C3CCN(CC3)C(=O)C3CC3)c(CC)c1)CC2(C)C)C(O)=O InChI=1S/C39H45N5O3/c1-5-26-21-25(13-16-29(26)27-17-19-42(20-18-27)37(45)28-14-15-28)23-43-24-39(3,4)32-10-7-9-30(36(32)43)33-11-8-12-35(41-33)44-34(6-2)31(22-40-44)38(46)47/h7-13,16,21-22,27-28H,5-6,14-15,17-20,23-24H2,1-4H3,(H,46,47) QSMVOFKEBICLBY-UHFFFAOYSA-N 430919 Example 23-A. (4-(4-((7-Bromo-3,3-dimethylindolin-1-yl)methyl)-2-ethylphenyl)piperidin-1-yl)(cyclopropyl)methanone::US10550102, Example 23 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430919&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627998 438639923 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874745 CCC[C@H](O)C(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C38H45N5O4/c1-4-9-34(44)37(45)42-20-18-25(19-21-42)28-16-15-27(22-24(28)5-2)40-32-17-14-26-10-7-11-29(36(26)32)31-12-8-13-35(41-31)43-33(6-3)30(23-39-43)38(46)47/h7-8,10-13,15-16,22-23,25,32,34,40,44H,4-6,9,14,17-21H2,1-3H3,(H,46,47)/t32?,34-/m0/s1 CQNHQJCPNIRZHR-DDKACPBQSA-N 430920 US10550102, Example 49a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430920&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627968 438639924 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874746 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2CCN(Cc3ccc(cc3C)C3CCNCC3)c12 InChI=1S/C33H37N5O2/c1-4-40-33(39)29-20-35-38(23(29)3)31-10-6-9-30(36-31)28-8-5-7-25-15-18-37(32(25)28)21-27-12-11-26(19-22(27)2)24-13-16-34-17-14-24/h5-12,19-20,24,34H,4,13-18,21H2,1-3H3 RRFOAFYWIBQTMM-UHFFFAOYSA-N 430921 Example 24-A. Ethyl 5-methyl-1-(6-(1-(2-methyl-4-(piperidin-4-yl)benzyl)indolin-7-yl)pyridin-2-yl)-1H-pyrazole-4-carboxylate::US10550102, Example 24 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 7.90 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430921&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628116 438639925 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874747 CCC[C@H](O)C(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(=O)OCC)c2CC)cc1CC InChI=1S/C40H49N5O4/c1-5-11-36(46)39(47)44-22-20-27(21-23-44)30-18-17-29(24-26(30)6-2)42-34-19-16-28-12-9-13-31(38(28)34)33-14-10-15-37(43-33)45-35(7-3)32(25-41-45)40(48)49-8-4/h9-10,12-15,17-18,24-25,27,34,36,42,46H,5-8,11,16,19-23H2,1-4H3/t34?,36-/m0/s1 XWTXNBDPFUJZBJ-XTNWEWJCSA-N 430922 US10550102, Example 49b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 20.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430922&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627982 438639926 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874748 OC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCN(Cc3ccc4CN(Cc5ccccn5)CCc4c3)c12 InChI=1S/C34H29F3N6O2/c35-34(36,37)32-28(33(44)45)18-39-43(32)30-9-4-8-29(40-30)27-7-3-5-23-13-16-42(31(23)27)19-22-10-11-25-20-41(15-12-24(25)17-22)21-26-6-1-2-14-38-26/h1-11,14,17-18H,12-13,15-16,19-21H2,(H,44,45) PFZDTLMYYYIBIF-UHFFFAOYSA-N 430923 Example 25-A. Ethyl 1-(6-(1-((1,2,3,4-tetrahydroisoquinolin-6-yl)methyl)indolin-7-yl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate::US10550102, Example 25 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430923&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628048 438639927 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874749 CC[C@H](O)C(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C37H43N5O4/c1-4-23-21-26(14-15-27(23)24-17-19-41(20-18-24)36(44)33(43)6-3)39-31-16-13-25-9-7-10-28(35(25)31)30-11-8-12-34(40-30)42-32(5-2)29(22-38-42)37(45)46/h7-12,14-15,21-22,24,31,33,39,43H,4-6,13,16-20H2,1-3H3,(H,45,46)/t31?,33-/m0/s1 CAYFSDFGAMTCTA-STJUJJKNSA-N 430924 US10550102, Example 50a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430924&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628029 438639928 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874750 OC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2ccn(Cc3ccc(cc3)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C34H30F3N5O3/c35-34(36,37)31-27(33(44)45)19-38-42(31)29-6-2-5-28(39-29)26-4-1-3-24-15-18-41(30(24)26)20-21-7-9-22(10-8-21)23-13-16-40(17-14-23)32(43)25-11-12-25/h1-10,15,18-19,23,25H,11-14,16-17,20H2,(H,44,45) JQRVRXKZFGHJGT-UHFFFAOYSA-N 430925 US10550102, Example 26 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 21.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430925&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627931 438639929 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874751 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)[C@@H](O)CC)c(CC)c3)c12 InChI=1S/C39H47N5O4/c1-5-25-23-28(16-17-29(25)26-19-21-43(22-20-26)38(46)35(45)7-3)41-33-18-15-27-11-9-12-30(37(27)33)32-13-10-14-36(42-32)44-34(6-2)31(24-40-44)39(47)48-8-4/h9-14,16-17,23-24,26,33,35,41,45H,5-8,15,18-22H2,1-4H3/t33?,35-/m0/s1 WFXKCLBMUAENAN-XZEQTHJSSA-N 430926 US10550102, Example 50b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 12.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430926&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627993 438639930 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874752 CCc1c(cnn1-c1cccc(n1)-c1cccc2ccn(Cc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C37H39N5O3/c1-3-25-21-24(11-14-29(25)26-15-18-40(19-16-26)36(43)28-12-13-28)23-41-20-17-27-7-5-8-30(35(27)41)32-9-6-10-34(39-32)42-33(4-2)31(22-38-42)37(44)45/h5-11,14,17,20-22,26,28H,3-4,12-13,15-16,18-19,23H2,1-2H3,(H,44,45) LDIYCOUSLGPFIT-UHFFFAOYSA-N 430927 US10550102, Example 27 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430927&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628031 438639931 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874753 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)OC(C)C)c(CC)c3)c12)C(O)=O InChI=1S/C37H43N5O4/c1-5-24-21-27(14-15-28(24)25-17-19-41(20-18-25)37(45)46-23(3)4)39-32-16-13-26-9-7-10-29(35(26)32)31-11-8-12-34(40-31)42-33(6-2)30(22-38-42)36(43)44/h7-12,14-15,21-23,25,32,39H,5-6,13,16-20H2,1-4H3,(H,43,44) GEKBULMSSFLKRS-UHFFFAOYSA-N 430928 US10550102, Example 51a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430928&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199923 438639932 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874754 CCc1cc(Cn2cc(C)c3cccc(-c4cccc(n4)-n4ncc(C(O)=O)c4F)c23)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H36FN5O3/c1-3-24-18-23(10-13-28(24)25-14-16-40(17-15-25)35(43)26-11-12-26)21-41-20-22(2)27-6-4-7-29(33(27)41)31-8-5-9-32(39-31)42-34(37)30(19-38-42)36(44)45/h4-10,13,18-20,25-26H,3,11-12,14-17,21H2,1-2H3,(H,44,45) OZSPJPSPLNPKBL-UHFFFAOYSA-N 430929 Example 28-A. Ethyl 1-(6-(1-(4-(1-(cyclopropanecarbonyl)piperidin-4-yl)-3-ethylbenzyl)-3-methyl-1H-indol-7-yl)pyridin-2-yl)-6-(trifluoromethyl)-1H-pyrazole-4-carboxylate::US10550102, Example 28 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 4.50 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430929&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 141657036 438639933 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874755 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)OC(C)C)c(CC)c3)c12 InChI=1S/C39H47N5O4/c1-6-26-23-29(16-17-30(26)27-19-21-43(22-20-27)39(46)48-25(4)5)41-34-18-15-28-11-9-12-31(37(28)34)33-13-10-14-36(42-33)44-35(7-2)32(24-40-44)38(45)47-8-3/h9-14,16-17,23-25,27,34,41H,6-8,15,18-22H2,1-5H3 RNIYCZWZTMEASN-UHFFFAOYSA-N 430930 US10550102, Example 51b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430930&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627897 438639934 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874756 CCOC(=O)N1CCC(CC1)c1ccc(O[C@H]2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C36H40N4O5/c1-4-23-21-26(14-15-27(23)24-17-19-39(20-18-24)36(43)44-6-3)45-32-16-13-25-9-7-10-28(34(25)32)30-11-8-12-33(38-30)40-31(5-2)29(22-37-40)35(41)42/h7-12,14-15,21-22,24,32H,4-6,13,16-20H2,1-3H3,(H,41,42)/t32-/m0/s1 KBVPUQZKNKDPAI-YTTGMZPUSA-N 430931 Example 29-A. (S)-tert-Butyl 4-(4-((7-(4-(4-(ethoxycarbonyl)-5-ethyl-1H-pyrazol-1-yl)pyridin-2-yl)-2,3-dihydro-1H-inden-1-yl)oxy)-2-ethylphenyl)piperidine-1-carboxylate::US10550102, Example 29 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430931&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627986 438639935 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874757 CCOC(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C36H41N5O4/c1-4-23-21-26(14-15-27(23)24-17-19-40(20-18-24)36(44)45-6-3)38-31-16-13-25-9-7-10-28(34(25)31)30-11-8-12-33(39-30)41-32(5-2)29(22-37-41)35(42)43/h7-12,14-15,21-22,24,31,38H,4-6,13,16-20H2,1-3H3,(H,42,43) IKSCPNSSONLODN-UHFFFAOYSA-N 430932 US10550102, Example (-)-52-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 19.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430932&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628119 438639936 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874758 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)[C@H](C)O)c(CC)c3)c12)C(O)=O InChI=1S/C36H40N4O5/c1-4-23-20-26(13-14-27(23)24-16-18-39(19-17-24)35(42)22(3)41)45-32-15-12-25-8-6-9-28(34(25)32)30-10-7-11-33(38-30)40-31(5-2)29(21-37-40)36(43)44/h6-11,13-14,20-22,24,32,41H,4-5,12,15-19H2,1-3H3,(H,43,44)/t22-,32-/m0/s1 CALSAVUQRHARLQ-ICACTRECSA-N 430933 Example 30-A. Ethyl 5-ethyl-6-((S)-3-(3-ethyl-4-(1-((S)-2-hydroxypropanoyl)piperidin-4-yl)phenoxy)-2,3-dihydro-1H-inden-4-yl)pyridin-2-yl)-1H-pyrazole-4-carboxylate::US10550102, Example 30 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430933&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628118 438639937 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874759 CCOC(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C36H41N5O4/c1-4-23-21-26(14-15-27(23)24-17-19-40(20-18-24)36(44)45-6-3)38-31-16-13-25-9-7-10-28(34(25)31)30-11-8-12-33(39-30)41-32(5-2)29(22-37-41)35(42)43/h7-12,14-15,21-22,24,31,38H,4-6,13,16-20H2,1-3H3,(H,42,43) IKSCPNSSONLODN-UHFFFAOYSA-N 430934 US10550102, Example (+)-52-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430934&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628119 438639938 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874760 CCC[C@H](O)C(=O)N1CCC(CC1)c1ccc(O[C@H]2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C38H44N4O5/c1-4-9-33(43)37(44)41-20-18-25(19-21-41)28-16-15-27(22-24(28)5-2)47-34-17-14-26-10-7-11-29(36(26)34)31-12-8-13-35(40-31)42-32(6-3)30(23-39-42)38(45)46/h7-8,10-13,15-16,22-23,25,33-34,43H,4-6,9,14,17-21H2,1-3H3,(H,45,46)/t33-,34-/m0/s1 KWJUSQNIOLBLHU-HEVIKAOCSA-N 430935 US10550102, Example 31-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430935&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199931 438639939 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874761 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)OC)c(CC)c3)c12)C(O)=O InChI=1S/C35H39N5O4/c1-4-22-20-25(13-14-26(22)23-16-18-39(19-17-23)35(43)44-3)37-30-15-12-24-8-6-9-27(33(24)30)29-10-7-11-32(38-29)40-31(5-2)28(21-36-40)34(41)42/h6-11,13-14,20-21,23,30,37H,4-5,12,15-19H2,1-3H3,(H,41,42) OHSNHZPNBFTLAO-UHFFFAOYSA-N 430936 US10550102, Example (-)-52-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430936&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627948 438639940 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874762 CC[C@H](O)C(=O)N1CCC(CC1)c1ccc(O[C@H]2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C37H42N4O5/c1-4-23-21-26(14-15-27(23)24-17-19-40(20-18-24)36(43)32(42)6-3)46-33-16-13-25-9-7-10-28(35(25)33)30-11-8-12-34(39-30)41-31(5-2)29(22-38-41)37(44)45/h7-12,14-15,21-22,24,32-33,42H,4-6,13,16-20H2,1-3H3,(H,44,45)/t32-,33-/m0/s1 ZGOWHXGXPMVARF-LQJZCPKCSA-N 430937 US10550102, Example 31-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430937&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199934 438639941 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874763 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)OC)c(CC)c3)c12)C(O)=O InChI=1S/C35H39N5O4/c1-4-22-20-25(13-14-26(22)23-16-18-39(19-17-23)35(43)44-3)37-30-15-12-24-8-6-9-27(33(24)30)29-10-7-11-32(38-29)40-31(5-2)28(21-36-40)34(41)42/h6-11,13-14,20-21,23,30,37H,4-5,12,15-19H2,1-3H3,(H,41,42) OHSNHZPNBFTLAO-UHFFFAOYSA-N 430938 US10550102, Example (+)-52-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430938&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627948 438639942 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874764 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)[C@@H](C)CO)c(CC)c3)c12)C(O)=O InChI=1S/C37H42N4O5/c1-4-24-20-27(13-14-28(24)25-16-18-40(19-17-25)36(43)23(3)22-42)46-33-15-12-26-8-6-9-29(35(26)33)31-10-7-11-34(39-31)41-32(5-2)30(21-38-41)37(44)45/h6-11,13-14,20-21,23,25,33,42H,4-5,12,15-19,22H2,1-3H3,(H,44,45)/t23-,33-/m0/s1 GJSBYIBLLKPDLR-WYOOIXGGSA-N 430939 US10550102, Example 31-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430939&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199920 438639943 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874765 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)OCC=C)c(CC)c3)c12)C(O)=O InChI=1S/C37H41N5O4/c1-4-21-46-37(45)41-19-17-25(18-20-41)28-15-14-27(22-24(28)5-2)39-32-16-13-26-9-7-10-29(35(26)32)31-11-8-12-34(40-31)42-33(6-3)30(23-38-42)36(43)44/h4,7-12,14-15,22-23,25,32,39H,1,5-6,13,16-21H2,2-3H3,(H,43,44) HBYVZRSMLCZCDD-UHFFFAOYSA-N 430940 US10550102, Example (-)-52-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430940&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199868 438639944 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874766 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)C4(O)CCC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H42N4O5/c1-3-24-22-27(13-14-28(24)25-16-20-41(21-17-25)37(45)38(46)18-7-19-38)47-33-15-12-26-8-5-9-29(35(26)33)31-10-6-11-34(40-31)42-32(4-2)30(23-39-42)36(43)44/h5-6,8-11,13-14,22-23,25,33,46H,3-4,7,12,15-21H2,1-2H3,(H,43,44)/t33-/m0/s1 HGJXQVYCNIHMHG-XIFFEERXSA-N 430941 US10550102, Example 31-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430941&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199903 438639945 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874767 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)OCC=C)c(CC)c3)c12)C(O)=O InChI=1S/C37H41N5O4/c1-4-21-46-37(45)41-19-17-25(18-20-41)28-15-14-27(22-24(28)5-2)39-32-16-13-26-9-7-10-29(35(26)32)31-11-8-12-34(40-31)42-33(6-3)30(23-38-42)36(43)44/h4,7-12,14-15,22-23,25,32,39H,1,5-6,13,16-21H2,2-3H3,(H,43,44) HBYVZRSMLCZCDD-UHFFFAOYSA-N 430942 US10550102, Example (+)-52-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430942&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199868 438639946 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874768 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)C(C)CCO)c(CC)c3)c12)C(O)=O InChI=1S/C38H44N4O5/c1-4-25-22-28(13-14-29(25)26-16-19-41(20-17-26)37(44)24(3)18-21-43)47-34-15-12-27-8-6-9-30(36(27)34)32-10-7-11-35(40-32)42-33(5-2)31(23-39-42)38(45)46/h6-11,13-14,22-24,26,34,43H,4-5,12,15-21H2,1-3H3,(H,45,46)/t24?,34-/m0/s1 QYACXCLWVKFVCA-NEYGVQFESA-N 430943 US10550102, Example 32a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430943&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628113 438639947 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874769 CCOC(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C34H37N5O4/c1-4-43-34(42)38-17-15-23(16-18-38)25-12-13-28(21(2)19-25)36-30-14-11-24-7-5-8-26(32(24)30)29-9-6-10-31(37-29)39-22(3)27(20-35-39)33(40)41/h5-10,12-13,19-20,23,30,36H,4,11,14-18H2,1-3H3,(H,40,41) SQVLMFFTCUUEHB-UHFFFAOYSA-N 430944 US10550102, Example 52-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430944&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199904 438639948 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874770 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@@H](Oc3ccc(C4CCN(CC4)C(=O)C(C)CCO)c(CC)c3)c12)C(O)=O InChI=1S/C38H44N4O5/c1-4-25-22-28(13-14-29(25)26-16-19-41(20-17-26)37(44)24(3)18-21-43)47-34-15-12-27-8-6-9-30(36(27)34)32-10-7-11-35(40-32)42-33(5-2)31(23-39-42)38(45)46/h6-11,13-14,22-24,26,34,43H,4-5,12,15-21H2,1-3H3,(H,45,46)/t24?,34-/m1/s1 QYACXCLWVKFVCA-PSEQAOQMSA-N 430945 US10550102, Example 32b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430945&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 154825667 438639949 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874771 COCCOC(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C35H39N5O5/c1-22-20-26(24-14-16-39(17-15-24)35(43)45-19-18-44-3)11-12-29(22)37-31-13-10-25-6-4-7-27(33(25)31)30-8-5-9-32(38-30)40-23(2)28(21-36-40)34(41)42/h4-9,11-12,20-21,24,31,37H,10,13-19H2,1-3H3,(H,41,42) JYWOWJWZEWSZDY-UHFFFAOYSA-N 430946 US10550102, Example 52-5 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430946&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199859 438639950 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874772 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)C4(O)CC4)c(CC)c3)c12)C(O)=O InChI=1S/C37H40N4O5/c1-3-23-21-26(12-13-27(23)24-15-19-40(20-16-24)36(44)37(45)17-18-37)46-32-14-11-25-7-5-8-28(34(25)32)30-9-6-10-33(39-30)41-31(4-2)29(22-38-41)35(42)43/h5-10,12-13,21-22,24,32,45H,3-4,11,14-20H2,1-2H3,(H,42,43)/t32-/m0/s1 XQSFRGIOOYAORA-YTTGMZPUSA-N 430947 Example 33-A. (S)-1-(6-(3-(4-(1-(tert-Butoxycarbonyl)piperidin-4-yl)-3-ethylphenoxy)-2,3-dihydro-1H-inden-4-yl)pyridin-2-yl)-5-ethyl-1H-pyrazole-4-carboxylic Acid::US10550102, Example 33 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430947&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199929 438639951 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874773 CC(=C)OC(=O)N1CCC(CC1)c1ccc(NC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C35H37N5O4/c1-21(2)44-35(43)39-17-15-24(16-18-39)26-12-13-29(22(3)19-26)37-31-14-11-25-7-5-8-27(33(25)31)30-9-6-10-32(38-30)40-23(4)28(20-36-40)34(41)42/h5-10,12-13,19-20,24,31,37H,1,11,14-18H2,2-4H3,(H,41,42) ZVCWAPWGVOQJAT-UHFFFAOYSA-N 430948 US10550102, Example 52-6 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430948&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199895 438639952 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874774 Cc1c(cnn1-c1cccc(n1)-c1cccc2OCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C34H35N5O4/c1-20-17-24(22-13-15-38(16-14-22)33(40)23-9-10-23)11-12-27(20)36-29-19-43-30-7-3-5-25(32(29)30)28-6-4-8-31(37-28)39-21(2)26(18-35-39)34(41)42/h3-8,11-12,17-18,22-23,29,36H,9-10,13-16,19H2,1-2H3,(H,41,42) SIVXDCZRFCIWJG-UHFFFAOYSA-N 430949 US10550102, Example 34a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430949&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628123 438639953 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874775 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C37H41N5O3/c1-3-23-21-27(14-15-28(23)24-17-19-41(20-18-24)36(43)26-11-12-26)39-32-16-13-25-7-5-8-29(35(25)32)31-9-6-10-34(40-31)42-33(4-2)30(22-38-42)37(44)45/h5-10,14-15,21-22,24,26,32,39H,3-4,11-13,16-20H2,1-2H3,(H,44,45) VZYKNPNPFKVFHK-UHFFFAOYSA-N 430950 US10550102, Example (-)-53-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 21.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430950&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199933 438639954 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874776 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2OCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C36H39N5O4/c1-4-44-36(43)28-20-37-41(23(28)3)33-10-6-8-30(39-33)27-7-5-9-32-34(27)31(21-45-32)38-29-14-13-26(19-22(29)2)24-15-17-40(18-16-24)35(42)25-11-12-25/h5-10,13-14,19-20,24-25,31,38H,4,11-12,15-18,21H2,1-3H3 WFHLUVNJWMERGW-UHFFFAOYSA-N 430951 US10550102, Example 34b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.90 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430951&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628102 438639955 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874777 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C37H41N5O3/c1-3-23-21-27(14-15-28(23)24-17-19-41(20-18-24)36(43)26-11-12-26)39-32-16-13-25-7-5-8-29(35(25)32)31-9-6-10-34(40-31)42-33(4-2)30(22-38-42)37(44)45/h5-10,14-15,21-22,24,26,32,39H,3-4,11-13,16-20H2,1-2H3,(H,44,45) VZYKNPNPFKVFHK-UHFFFAOYSA-N 430952 US10550102, Example (+)-53-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430952&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199933 438639956 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874778 C[C@H](O)C(=O)N1CCC(CC1)c1ccc(NC2COc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)c(C)c1 InChI=1S/C33H35N5O5/c1-19-16-23(22-12-14-37(15-13-22)32(40)21(3)39)10-11-26(19)35-28-18-43-29-8-4-6-24(31(28)29)27-7-5-9-30(36-27)38-20(2)25(17-34-38)33(41)42/h4-11,16-17,21-22,28,35,39H,12-15,18H2,1-3H3,(H,41,42)/t21-,28?/m0/s1 GUBBIDWSXKHCJW-QDLLFRBVSA-N 430953 US10550102, Example 35a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430953&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628051 438639957 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874779 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2OCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)OC(C)(C)C)c12 InChI=1S/C37H43N5O5/c1-7-45-35(43)28-21-38-42(24(28)3)33-13-9-11-30(40-33)27-10-8-12-32-34(27)31(22-46-32)39-29-15-14-26(20-23(29)2)25-16-18-41(19-17-25)36(44)47-37(4,5)6/h8-15,20-21,25,31,39H,7,16-19,22H2,1-6H3 KGVRWJAWXBQVMI-UHFFFAOYSA-N 430954 US10550102, Example 35b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 17.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430954&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130200010 438639958 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874780 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)CC4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H43N5O3/c1-3-25-22-28(14-15-29(25)26-17-19-42(20-18-26)36(44)21-24-11-12-24)40-33-16-13-27-7-5-8-30(37(27)33)32-9-6-10-35(41-32)43-34(4-2)31(23-39-43)38(45)46/h5-10,14-15,22-24,26,33,40H,3-4,11-13,16-21H2,1-2H3,(H,45,46) CAXJQKGAFDAKJY-UHFFFAOYSA-N 430955 US10550102, Example (+)-53-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430955&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627935 438639959 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874781 CCc1cc(NC2COc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C(F)(F)F)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C35H34F3N5O4/c1-2-20-17-23(11-12-24(20)21-13-15-42(16-14-21)33(44)22-9-10-22)40-28-19-47-29-7-3-5-25(31(28)29)27-6-4-8-30(41-27)43-32(35(36,37)38)26(18-39-43)34(45)46/h3-8,11-12,17-18,21-22,28,40H,2,9-10,13-16,19H2,1H3,(H,45,46) JBEUIAAPLIIBCZ-UHFFFAOYSA-N 430956 US10550102, Example (+)-36-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430956&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628004 438639960 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874782 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3c(C)cc(cc3F)C3CCN(CC3)C(=O)CC3CC3)c12)C(O)=O InChI=1S/C36H38FN5O3/c1-21-17-26(24-13-15-41(16-14-24)33(43)18-23-9-10-23)19-29(37)35(21)40-31-12-11-25-5-3-6-27(34(25)31)30-7-4-8-32(39-30)42-22(2)28(20-38-42)36(44)45/h3-8,17,19-20,23-24,31,40H,9-16,18H2,1-2H3,(H,44,45) LZOIQSXMLQGEDC-UHFFFAOYSA-N 430957 US10550102, Example (+)-53-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.50 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430957&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627927 438639961 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874783 CCc1cc(NC2COc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C(F)(F)F)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C35H34F3N5O4/c1-2-20-17-23(11-12-24(20)21-13-15-42(16-14-21)33(44)22-9-10-22)40-28-19-47-29-7-3-5-25(31(28)29)27-6-4-8-30(41-27)43-32(35(36,37)38)26(18-39-43)34(45)46/h3-8,11-12,17-18,21-22,28,40H,2,9-10,13-16,19H2,1H3,(H,45,46) JBEUIAAPLIIBCZ-UHFFFAOYSA-N 430958 US10550102, Example (-)-36-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 20.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430958&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628004 438639962 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874784 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3c(C)cc(cc3F)C3CCN(CC3)C(=O)CC3CC3)c12)C(O)=O InChI=1S/C36H38FN5O3/c1-21-17-26(24-13-15-41(16-14-24)33(43)18-23-9-10-23)19-29(37)35(21)40-31-12-11-25-5-3-6-27(34(25)31)30-7-4-8-32(39-30)42-22(2)28(20-38-42)36(44)45/h3-8,17,19-20,23-24,31,40H,9-16,18H2,1-2H3,(H,44,45) LZOIQSXMLQGEDC-UHFFFAOYSA-N 430959 US10550102, Example (-)-53-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 59.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430959&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627927 438639963 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874785 CCc1c(cnn1-c1cccc(n1)-c1cccc2OCC(Nc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C36H39N5O4/c1-3-22-19-25(13-14-26(22)23-15-17-40(18-16-23)35(42)24-11-12-24)38-30-21-45-32-9-5-7-27(34(30)32)29-8-6-10-33(39-29)41-31(4-2)28(20-37-41)36(43)44/h5-10,13-14,19-20,23-24,30,38H,3-4,11-12,15-18,21H2,1-2H3,(H,43,44) IAABICZNJYRQJV-UHFFFAOYSA-N 430960 US10550102, Example (+)-36-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430960&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627965 438639964 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874786 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C35H35F2N5O3/c1-20-18-24(21-14-16-41(17-15-21)34(43)23-8-9-23)11-12-27(20)39-29-13-10-22-4-2-5-25(31(22)29)28-6-3-7-30(40-28)42-32(33(36)37)26(19-38-42)35(44)45/h2-7,11-12,18-19,21,23,29,33,39H,8-10,13-17H2,1H3,(H,44,45) RSVQQMDRQKMUKO-UHFFFAOYSA-N 430961 US10550102, Example (+)-53-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430961&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628078 438639965 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874787 CCc1c(cnn1-c1cccc(n1)-c1cccc2OCC(Nc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C36H39N5O4/c1-3-22-19-25(13-14-26(22)23-15-17-40(18-16-23)35(42)24-11-12-24)38-30-21-45-32-9-5-7-27(34(30)32)29-8-6-10-33(39-29)41-31(4-2)28(20-37-41)36(43)44/h5-10,13-14,19-20,23-24,30,38H,3-4,11-12,15-18,21H2,1-2H3,(H,43,44) IAABICZNJYRQJV-UHFFFAOYSA-N 430962 US10550102, Example (-)-36-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430962&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627965 438639966 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874788 CCOC(=O)c1cnn(c1C)-c1cccc(c1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C39H43N3O3/c1-4-45-39(44)36-24-40-42(26(36)3)34-9-5-8-32(23-34)35-10-6-7-28-11-16-33(37(28)35)22-30-14-15-31(21-25(30)2)27-17-19-41(20-18-27)38(43)29-12-13-29/h5-10,14-15,21,23-24,27,29,33H,4,11-13,16-20,22H2,1-3H3 MWGJSSGGZZMVCE-UHFFFAOYSA-N 430963 US10550102, Example (-)-53-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 24.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430963&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211505 438639967 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874789 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H38N4O3/c1-22-19-28(24-15-17-39(18-16-24)35(41)26-10-11-26)13-12-27(22)20-29-14-9-25-5-3-6-30(34(25)29)32-7-4-8-33(38-32)40-23(2)31(21-37-40)36(42)43/h3-8,12-13,19,21,24,26,29H,9-11,14-18,20H2,1-2H3,(H,42,43) NBLYSDQTFQPHCS-UHFFFAOYSA-N 430964 US10550102, Example 37. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430964&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627958 438639968 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874790 CCOC(=O)c1cnn(c1C)-c1cccc(c1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C39H43N3O3/c1-4-45-39(44)36-24-40-42(26(36)3)34-9-5-8-32(23-34)35-10-6-7-28-11-16-33(37(28)35)22-30-14-15-31(21-25(30)2)27-17-19-41(20-18-27)38(43)29-12-13-29/h5-10,14-15,21,23-24,27,29,33H,4,11-13,16-20,22H2,1-3H3 MWGJSSGGZZMVCE-UHFFFAOYSA-N 430965 US10550102, Example 54. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 168 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430965&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211505 438639969 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874791 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H38N4O3/c1-22-19-28(24-15-17-39(18-16-24)35(41)26-10-11-26)13-12-27(22)20-29-14-9-25-5-3-6-30(34(25)29)32-7-4-8-33(38-32)40-23(2)31(21-37-40)36(42)43/h3-8,12-13,19,21,24,26,29H,9-11,14-18,20H2,1-2H3,(H,42,43) NBLYSDQTFQPHCS-UHFFFAOYSA-N 430966 US10550102, Example 37. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 6.30 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430966&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627958 438639970 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874792 CCOC(=O)c1cnn(c1C)-c1cccc(c1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C39H43N3O3/c1-4-45-39(44)36-24-40-42(26(36)3)34-9-5-8-32(23-34)35-10-6-7-28-11-16-33(37(28)35)22-30-14-15-31(21-25(30)2)27-17-19-41(20-18-27)38(43)29-12-13-29/h5-10,14-15,21,23-24,27,29,33H,4,11-13,16-20,22H2,1-3H3 MWGJSSGGZZMVCE-UHFFFAOYSA-N 430967 US10550102, Example 54. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430967&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211505 438639971 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874793 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H42N4O3/c1-3-25-21-24(11-16-30(25)26-17-19-41(20-18-26)37(43)28-13-14-28)22-29-15-12-27-7-5-8-31(36(27)29)33-9-6-10-35(40-33)42-34(4-2)32(23-39-42)38(44)45/h5-11,16,21,23,26,28-29H,3-4,12-15,17-20,22H2,1-2H3,(H,44,45) OVPUWFMXOIJKFN-UHFFFAOYSA-N 430968 US10550102, Example 38-1 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 17.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430968&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627901 438639972 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874794 CCc1cc(CC2CCc3cccc(c23)-c2cccc(c2)-n2ncc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C38H41N3O3/c1-3-26-20-25(10-15-33(26)27-16-18-40(19-17-27)37(42)29-12-13-29)21-31-14-11-28-6-5-9-34(36(28)31)30-7-4-8-32(22-30)41-24(2)35(23-39-41)38(43)44/h4-10,15,20,22-23,27,29,31H,3,11-14,16-19,21H2,1-2H3,(H,43,44) OQPXHRUQXSEFJX-UHFFFAOYSA-N 430969 US10550102, Example 55-1 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 15.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430969&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627903 438639973 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874795 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H42N4O3/c1-3-25-21-24(11-16-30(25)26-17-19-41(20-18-26)37(43)28-13-14-28)22-29-15-12-27-7-5-8-31(36(27)29)33-9-6-10-35(40-33)42-34(4-2)32(23-39-42)38(44)45/h5-11,16,21,23,26,28-29H,3-4,12-15,17-20,22H2,1-2H3,(H,44,45) OVPUWFMXOIJKFN-UHFFFAOYSA-N 430970 US10550102, Example 38-1 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430970&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627901 438639974 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874796 CCc1cc(CC2CCc3cccc(c23)-c2cccc(c2)-n2ncc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C38H41N3O3/c1-3-26-20-25(10-15-33(26)27-16-18-40(19-17-27)37(42)29-12-13-29)21-31-14-11-28-6-5-9-34(36(28)31)30-7-4-8-32(22-30)41-24(2)35(23-39-41)38(43)44/h4-10,15,20,22-23,27,29,31H,3,11-14,16-19,21H2,1-2H3,(H,43,44) OQPXHRUQXSEFJX-UHFFFAOYSA-N 430971 US10550102, Example 55-1 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430971&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627903 438639975 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874797 CCc1cc(CC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C37H40N4O3/c1-3-25-20-24(10-15-30(25)26-16-18-40(19-17-26)36(42)28-12-13-28)21-29-14-11-27-6-4-7-31(35(27)29)33-8-5-9-34(39-33)41-23(2)32(22-38-41)37(43)44/h4-10,15,20,22,26,28-29H,3,11-14,16-19,21H2,1-2H3,(H,43,44) MTLPKDBOTZWODL-UHFFFAOYSA-N 430972 US10550102, Example 38-2 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 9.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430972&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627910 438639976 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874798 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(c1)-n1ncc(C(O)=O)c1C(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H36F2N4O3/c1-21-18-25(22-14-16-41(17-15-22)35(43)24-8-9-24)11-12-30(21)40-31-13-10-23-4-3-7-28(32(23)31)26-5-2-6-27(19-26)42-33(34(37)38)29(20-39-42)36(44)45/h2-7,11-12,18-20,22,24,31,34,40H,8-10,13-17H2,1H3,(H,44,45) MRDHRPOJBGFURE-UHFFFAOYSA-N 430973 US10550102, Example 55-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430973&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199913 438639977 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874799 CCc1cc(CC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2C)ccc1C1CCN(CC1)C(=O)C1CC1 InChI=1S/C37H40N4O3/c1-3-25-20-24(10-15-30(25)26-16-18-40(19-17-26)36(42)28-12-13-28)21-29-14-11-27-6-4-7-31(35(27)29)33-8-5-9-34(39-33)41-23(2)32(22-38-41)37(43)44/h4-10,15,20,22,26,28-29H,3,11-14,16-19,21H2,1-2H3,(H,43,44) MTLPKDBOTZWODL-UHFFFAOYSA-N 430974 US10550102, Example 38-2 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430974&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627910 438639978 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874800 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(c1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC1)C(=O)CO InChI=1S/C34H33F3N4O4/c1-20-16-23(21-12-14-40(15-13-21)30(43)19-42)9-10-28(20)39-29-11-8-22-4-3-7-26(31(22)29)24-5-2-6-25(17-24)41-32(34(35,36)37)27(18-38-41)33(44)45/h2-7,9-10,16-18,21,29,39,42H,8,11-15,19H2,1H3,(H,44,45) XJVNROFUZICFMD-UHFFFAOYSA-N 430975 Example 56-A. a). (+-)-tert-Butyl 4-(4-((7-(3-(4-(ethoxycarbonyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)amino)-3-methylphenyl)piperidine-1-carboxylate::US10550102, Example 56 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430975&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199941 438639979 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874801 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C37H40N4O3/c1-3-33-31(37(43)44)22-38-41(33)34-9-5-8-32(39-34)30-7-4-6-25-10-15-29(35(25)30)21-27-13-14-28(20-23(27)2)24-16-18-40(19-17-24)36(42)26-11-12-26/h4-9,13-14,20,22,24,26,29H,3,10-12,15-19,21H2,1-2H3,(H,43,44) HHHIJZSWPMQHSU-UHFFFAOYSA-N 430976 US10550102, Example 38-3 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430976&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627939 438639980 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874802 Cc1cc(ccc1NC1CCc2cccc(c12)-c1cccc(n1)-n1ncc(C(O)=O)c1CC(F)(F)F)C1CCN(CC1)C(=O)C1CC1 InChI=1S/C36H36F3N5O3/c1-21-18-25(22-14-16-43(17-15-22)34(45)24-8-9-24)11-12-28(21)41-30-13-10-23-4-2-5-26(33(23)30)29-6-3-7-32(42-29)44-31(19-36(37,38)39)27(20-40-44)35(46)47/h2-7,11-12,18,20,22,24,30,41H,8-10,13-17,19H2,1H3,(H,46,47) VVHRQMLOQJQCQV-UHFFFAOYSA-N 430977 US10550102, Example 57 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430977&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628050 438639981 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874803 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C37H40N4O3/c1-3-33-31(37(43)44)22-38-41(33)34-9-5-8-32(39-34)30-7-4-6-25-10-15-29(35(25)30)21-27-13-14-28(20-23(27)2)24-16-18-40(19-17-24)36(42)26-11-12-26/h4-9,13-14,20,22,24,26,29H,3,10-12,15-19,21H2,1-2H3,(H,43,44) HHHIJZSWPMQHSU-UHFFFAOYSA-N 430978 US10550102, Example 38-3 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 33.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430978&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627939 438639982 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874804 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)c3nnc(C)o3)c12 InChI=1S/C36H39N7O3/c1-5-45-35(44)29-21-37-43(23(29)3)33-11-7-10-31(39-33)28-9-6-8-26-12-15-32(34(26)28)38-30-14-13-27(20-22(30)2)25-16-18-42(19-17-25)36-41-40-24(4)46-36/h6-11,13-14,20-21,25,32,38H,5,12,15-19H2,1-4H3 XDEAUSRHVZGLDC-UHFFFAOYSA-N 430979 US10550102, Example 58. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.20 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430979&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211506 438639983 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874805 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(C4CCN(CC4)C(=O)[C@H](C)O)c(CC)c3)c12)C(O)=O InChI=1S/C37H42N4O4/c1-4-25-20-24(12-15-29(25)26-16-18-40(19-17-26)36(43)23(3)42)21-28-14-13-27-8-6-9-30(35(27)28)32-10-7-11-34(39-32)41-33(5-2)31(22-38-41)37(44)45/h6-12,15,20,22-23,26,28,42H,4-5,13-14,16-19,21H2,1-3H3,(H,44,45)/t23-,28?/m0/s1 HQPPWIQPOXRUNB-UHFKCPIBSA-N 430980 US10550102, Example 39. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430980&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628042 438639984 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874806 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)c3nnc(C)o3)c12 InChI=1S/C36H39N7O3/c1-5-45-35(44)29-21-37-43(23(29)3)33-11-7-10-31(39-33)28-9-6-8-26-12-15-32(34(26)28)38-30-14-13-27(20-22(30)2)25-16-18-42(19-17-25)36-41-40-24(4)46-36/h6-11,13-14,20-21,25,32,38H,5,12,15-19H2,1-4H3 XDEAUSRHVZGLDC-UHFFFAOYSA-N 430981 US10550102, Example 58. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430981&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211506 438639985 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874807 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(C4CCN(CC4)C(=O)[C@H](C)O)c(CC)c3)c12)C(O)=O InChI=1S/C37H42N4O4/c1-4-25-20-24(12-15-29(25)26-16-18-40(19-17-26)36(43)23(3)42)21-28-14-13-27-8-6-9-30(35(27)28)32-10-7-11-34(39-32)41-33(5-2)31(22-38-41)37(44)45/h6-12,15,20,22-23,26,28,42H,4-5,13-14,16-19,21H2,1-3H3,(H,44,45)/t23-,28?/m0/s1 HQPPWIQPOXRUNB-UHFKCPIBSA-N 430982 US10550102, Example 39. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430982&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628042 438639986 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874808 CCOC(=O)c1cnn(c1C)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)c3ccccn3)c12 InChI=1S/C38H40N6O2/c1-4-46-38(45)31-24-40-44(26(31)3)36-13-8-11-33(42-36)30-10-7-9-28-14-17-34(37(28)30)41-32-16-15-29(23-25(32)2)27-18-21-43(22-19-27)35-12-5-6-20-39-35/h5-13,15-16,20,23-24,27,34,41H,4,14,17-19,21-22H2,1-3H3 MBMPHSSPLKBDLG-UHFFFAOYSA-N 430983 Example 59-A. (+-)-Ethyl 5-methyl-1-(6-(3-((2-methyl-4-(1-(pyridin-2-yl)piperidin-4-yl)phenyl)amino)-2,3-dihydro-1H-inden-4-yl)pyridin-2-yl)-1H-pyrazole-4-carboxylate::US10550102, Example 59 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430983&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130211507 438639987 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874809 CCC[C@H](O)C(=O)N1CCC(CC1)c1ccc(CC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C39H46N4O4/c1-4-9-35(44)38(45)42-20-18-27(19-21-42)30-17-14-25(22-26(30)5-2)23-29-16-15-28-10-7-11-31(37(28)29)33-12-8-13-36(41-33)43-34(6-3)32(24-40-43)39(46)47/h7-8,10-14,17,22,24,27,29,35,44H,4-6,9,15-16,18-21,23H2,1-3H3,(H,46,47)/t29?,35-/m0/s1 YYGCGAGADIUFIL-KEPYVBBOSA-N 430984 US10550102, Example 40-1 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 15.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430984&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627919 438639988 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874810 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C3CC3)c12)C(O)=O InChI=1S/C34H37N5O2/c1-21-19-25(23-15-17-38(18-16-23)26-11-12-26)10-13-29(21)36-31-14-9-24-5-3-6-27(33(24)31)30-7-4-8-32(37-30)39-22(2)28(20-35-39)34(40)41/h3-8,10,13,19-20,23,26,31,36H,9,11-12,14-18H2,1-2H3,(H,40,41) SHUOAROZAFWIEP-UHFFFAOYSA-N 430985 Example 60-A. (+-)-Ethyl 1-(6-(3-((4-(1-cyclopropylpiperidin-4-yl)-2-methylphenyl)amino)-2,3-dihydro-1H-inden-4-yl)pyridin-2-yl)-8-methyl-1H-pyrazole-4-carboxylate::US10550102, Example 60 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 5.30 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430985&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627974 438639989 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874811 CCC[C@H](O)C(=O)N1CCC(CC1)c1ccc(CC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C39H46N4O4/c1-4-9-35(44)38(45)42-20-18-27(19-21-42)30-17-14-25(22-26(30)5-2)23-29-16-15-28-10-7-11-31(37(28)29)33-12-8-13-36(41-33)43-34(6-3)32(24-40-43)39(46)47/h7-8,10-14,17,22,24,27,29,35,44H,4-6,9,15-16,18-21,23H2,1-3H3,(H,46,47)/t29?,35-/m0/s1 YYGCGAGADIUFIL-KEPYVBBOSA-N 430986 US10550102, Example 40-1 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430986&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627919 438639990 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874812 OC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C(F)(F)F)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C35H31F6N5O3/c36-34(37,38)25-17-22(19-13-15-45(16-14-19)32(47)21-7-8-21)10-11-27(25)43-28-12-9-20-3-1-4-23(30(20)28)26-5-2-6-29(44-26)46-31(35(39,40)41)24(18-42-46)33(48)49/h1-6,10-11,17-19,21,28,43H,7-9,12-16H2,(H,48,49) FYXNIIWCLPIUHE-UHFFFAOYSA-N 430987 US10550102, Example 61. b). (enantiomer-1)::US10550102, Example 61. b). (enantiomer-2) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 15.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430987&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 138569837 438639991 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874813 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)[C@H](C)O)c12)C(O)=O InChI=1S/C36H40N4O4/c1-4-32-30(36(43)44)21-37-40(32)33-10-6-9-31(38-33)29-8-5-7-25-11-14-28(34(25)29)20-26-12-13-27(19-22(26)2)24-15-17-39(18-16-24)35(42)23(3)41/h5-10,12-13,19,21,23-24,28,41H,4,11,14-18,20H2,1-3H3,(H,43,44)/t23-,28?/m0/s1 VIPWZPAYXILYHR-UHFKCPIBSA-N 430988 US10550102, Example 40-2 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 25.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430988&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627922 438639992 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874814 OC(=O)c1cnn(c1C(F)(F)F)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(cc3C(F)(F)F)C3CCN(CC3)C(=O)C3CC3)c12 InChI=1S/C35H31F6N5O3/c36-34(37,38)25-17-22(19-13-15-45(16-14-19)32(47)21-7-8-21)10-11-27(25)43-28-12-9-20-3-1-4-23(30(20)28)26-5-2-6-29(44-26)46-31(35(39,40)41)24(18-42-46)33(48)49/h1-6,10-11,17-19,21,28,43H,7-9,12-16H2,(H,48,49) FYXNIIWCLPIUHE-UHFFFAOYSA-N 430987 US10550102, Example 61. b). (enantiomer-1)::US10550102, Example 61. b). (enantiomer-2) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430987&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 138569837 438639991 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874815 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)[C@H](C)O)c12)C(O)=O InChI=1S/C36H40N4O4/c1-4-32-30(36(43)44)21-37-40(32)33-10-6-9-31(38-33)29-8-5-7-25-11-14-28(34(25)29)20-26-12-13-27(19-22(26)2)24-15-17-39(18-16-24)35(42)23(3)41/h5-10,12-13,19,21,23-24,28,41H,4,11,14-18,20H2,1-3H3,(H,43,44)/t23-,28?/m0/s1 VIPWZPAYXILYHR-UHFKCPIBSA-N 430990 US10550102, Example 40-2 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430990&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627922 438639993 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874816 Cc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ncc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C34H36N6O3/c1-20-17-25(22-13-15-39(16-14-22)33(41)24-9-10-24)18-35-32(20)38-29-12-11-23-5-3-6-26(31(23)29)28-7-4-8-30(37-28)40-21(2)27(19-36-40)34(42)43/h3-8,17-19,22,24,29H,9-16H2,1-2H3,(H,35,38)(H,42,43) PQCIVNVVTQYFED-UHFFFAOYSA-N 430991 Example 62-A. (+-)-Ethyl 1-(6-(3-((tert-butoxycarbonyl)amino)-2,3-dihydro-1H-inden-4-yl)pyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylate::US10550102, Example 62 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 6.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430991&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628114 438639994 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874817 CCC[C@H](O)C(=O)N1CCC(CC1)c1ccc(CC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)c(C)c1 InChI=1S/C38H44N4O4/c1-4-8-34(43)37(44)41-19-17-25(18-20-41)28-15-14-27(24(3)21-28)22-29-16-13-26-9-6-10-30(36(26)29)32-11-7-12-35(40-32)42-33(5-2)31(23-39-42)38(45)46/h6-7,9-12,14-15,21,23,25,29,34,43H,4-5,8,13,16-20,22H2,1-3H3,(H,45,46)/t29?,34-/m0/s1 NDTPANADGRIODZ-IPIVTTNMSA-N 430992 US10550102, Example 40-3 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 49.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430992&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627978 438639995 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874818 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)n3)c12)C(O)=O InChI=1S/C36H40N6O3/c1-3-28-25(22-17-19-41(20-18-22)35(43)24-11-12-24)14-16-32(38-28)39-30-15-13-23-7-5-8-26(34(23)30)29-9-6-10-33(40-29)42-31(4-2)27(21-37-42)36(44)45/h5-10,14,16,21-22,24,30H,3-4,11-13,15,17-20H2,1-2H3,(H,38,39)(H,44,45) FKIVFXZNYGOBRD-UHFFFAOYSA-N 430993 US10550102, Example 63a Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430993&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627907 438639996 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874819 CCC[C@H](O)C(=O)N1CCC(CC1)c1ccc(CC2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)c(C)c1 InChI=1S/C38H44N4O4/c1-4-8-34(43)37(44)41-19-17-25(18-20-41)28-15-14-27(24(3)21-28)22-29-16-13-26-9-6-10-30(36(26)29)32-11-7-12-35(40-32)42-33(5-2)31(23-39-42)38(45)46/h6-7,9-12,14-15,21,23,25,29,34,43H,4-5,8,13,16-20,22H2,1-3H3,(H,45,46)/t29?,34-/m0/s1 NDTPANADGRIODZ-IPIVTTNMSA-N 430994 US10550102, Example 40-3 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430994&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627978 438639997 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874820 CCOC(=O)c1cnn(c1CC)-c1cccc(n1)-c1cccc2CCC(Nc3ccc(C4CCN(CC4)C(=O)C4CC4)c(CC)n3)c12 InChI=1S/C38H44N6O3/c1-4-30-27(24-19-21-43(22-20-24)37(45)26-13-14-26)16-18-34(40-30)41-32-17-15-25-9-7-10-28(36(25)32)31-11-8-12-35(42-31)44-33(5-2)29(23-39-44)38(46)47-6-3/h7-12,16,18,23-24,26,32H,4-6,13-15,17,19-22H2,1-3H3,(H,40,41) UWUSQHKNRWMOQC-UHFFFAOYSA-N 430995 US10550102, Example 63b Guanylate cyclase soluble subunit alpha-1/beta-1 Human 60.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430995&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627904 438639998 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874821 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(C4CCN(CC4)C(=O)OC)c(CC)c3)c12)C(O)=O InChI=1S/C36H40N4O4/c1-4-24-20-23(12-15-28(24)25-16-18-39(19-17-25)36(43)44-3)21-27-14-13-26-8-6-9-29(34(26)27)31-10-7-11-33(38-31)40-32(5-2)30(22-37-40)35(41)42/h6-12,15,20,22,25,27H,4-5,13-14,16-19,21H2,1-3H3,(H,41,42) IPPIMDIVVBVFRT-UHFFFAOYSA-N 430996 US10550102, Example 41. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 18.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430996&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628053 438639999 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874822 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)OCc4ccccc4)c(CC)c3)c12)C(O)=O InChI=1S/C41H42N4O5/c1-3-28-24-31(17-18-32(28)29-20-22-44(23-21-29)41(48)49-26-27-10-6-5-7-11-27)50-37-19-16-30-12-8-13-33(39(30)37)35-14-9-15-38(43-35)45-36(4-2)34(25-42-45)40(46)47/h5-15,17-18,24-25,29,37H,3-4,16,19-23,26H2,1-2H3,(H,46,47)/t37-/m0/s1 UVXVNBNYBRVHBW-QNGWXLTQSA-N 430997 US10550102, Example 64-1 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 2.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430997&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627966 438640000 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874823 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(C4CCN(CC4)C(=O)OC)c(CC)c3)c12)C(O)=O InChI=1S/C36H40N4O4/c1-4-24-20-23(12-15-28(24)25-16-18-39(19-17-25)36(43)44-3)21-27-14-13-26-8-6-9-29(34(26)27)31-10-7-11-33(38-31)40-32(5-2)30(22-37-40)35(41)42/h6-12,15,20,22,25,27H,4-5,13-14,16-19,21H2,1-3H3,(H,41,42) IPPIMDIVVBVFRT-UHFFFAOYSA-N 430998 US10550102, Example 41. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430998&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628053 438640001 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874824 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)OCC(C)C)c(CC)c3)c12)C(O)=O InChI=1S/C38H44N4O5/c1-5-25-21-28(14-15-29(25)26-17-19-41(20-18-26)38(45)46-23-24(3)4)47-34-16-13-27-9-7-10-30(36(27)34)32-11-8-12-35(40-32)42-33(6-2)31(22-39-42)37(43)44/h7-12,14-15,21-22,24,26,34H,5-6,13,16-20,23H2,1-4H3,(H,43,44)/t34-/m0/s1 QNDRIACLWNNFNR-UMSFTDKQSA-N 430999 US10550102, Example 64-2 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 3.00 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=430999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=430999&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628033 438640002 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874825 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)OC)c12)C(O)=O InChI=1S/C35H38N4O4/c1-4-31-29(34(40)41)21-36-39(31)32-10-6-9-30(37-32)28-8-5-7-24-11-14-27(33(24)28)20-25-12-13-26(19-22(25)2)23-15-17-38(18-16-23)35(42)43-3/h5-10,12-13,19,21,23,27H,4,11,14-18,20H2,1-3H3,(H,40,41) NHLAUQQVKIVACU-UHFFFAOYSA-N 431000 US10550102, Example 42. b). (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 93.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431000&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627906 438640003 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874826 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)OC(C)C)c(CC)c3)c12)C(O)=O InChI=1S/C37H42N4O5/c1-5-24-21-27(14-15-28(24)25-17-19-40(20-18-25)37(44)45-23(3)4)46-33-16-13-26-9-7-10-29(35(26)33)31-11-8-12-34(39-31)41-32(6-2)30(22-38-41)36(42)43/h7-12,14-15,21-23,25,33H,5-6,13,16-20H2,1-4H3,(H,42,43)/t33-/m0/s1 KKLKCAVBQGNGPP-XIFFEERXSA-N 431001 US10550102, Example 64-3 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431001&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627952 438640004 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874827 CCc1c(cnn1-c1cccc(n1)-c1cccc2CCC(Cc3ccc(cc3C)C3CCN(CC3)C(=O)OC)c12)C(O)=O InChI=1S/C35H38N4O4/c1-4-31-29(34(40)41)21-36-39(31)32-10-6-9-30(37-32)28-8-5-7-24-11-14-27(33(24)28)20-25-12-13-26(19-22(25)2)23-15-17-38(18-16-23)35(42)43-3/h5-10,12-13,19,21,23,27H,4,11,14-18,20H2,1-3H3,(H,40,41) NHLAUQQVKIVACU-UHFFFAOYSA-N 431002 US10550102, Example 42. b). (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431002&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627906 438640005 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874828 CCCOC(=O)N1CCC(CC1)c1ccc(O[C@H]2CCc3cccc(c23)-c2cccc(n2)-n2ncc(C(O)=O)c2CC)cc1CC InChI=1S/C37H42N4O5/c1-4-21-45-37(44)40-19-17-25(18-20-40)28-15-14-27(22-24(28)5-2)46-33-16-13-26-9-7-10-29(35(26)33)31-11-8-12-34(39-31)41-32(6-3)30(23-38-41)36(42)43/h7-12,14-15,22-23,25,33H,4-6,13,16-21H2,1-3H3,(H,42,43)/t33-/m0/s1 HFURIWLOEYRITG-XIFFEERXSA-N 431003 US10550102, Example 64-4 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431003&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199971 438640006 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874829 Cc1cc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c2c(c1)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F InChI=1S/C36H36F3N5O3/c1-20-16-25-9-11-30(41-28-10-8-24(18-21(28)2)22-12-14-43(15-13-22)34(45)23-6-7-23)32(25)26(17-20)29-4-3-5-31(42-29)44-33(36(37,38)39)27(19-40-44)35(46)47/h3-5,8,10,16-19,22-23,30,41H,6-7,9,11-15H2,1-2H3,(H,46,47) ODHZMNOWYDDYOX-UHFFFAOYSA-N 431004 US10550102, Example 43 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.000 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431004&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627970 438640007 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874830 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)OCC=C)c(CC)c3)c12)C(O)=O InChI=1S/C37H40N4O5/c1-4-21-45-37(44)40-19-17-25(18-20-40)28-15-14-27(22-24(28)5-2)46-33-16-13-26-9-7-10-29(35(26)33)31-11-8-12-34(39-31)41-32(6-3)30(23-38-41)36(42)43/h4,7-12,14-15,22-23,25,33H,1,5-6,13,16-21H2,2-3H3,(H,42,43)/t33-/m0/s1 ODWBUNBGJYLROF-XIFFEERXSA-N 431005 US10550102, Example 64-5 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431005&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130200000 438640008 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874831 Cc1cc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c2c(c1)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F InChI=1S/C36H36F3N5O3/c1-20-16-25-9-11-30(41-28-10-8-24(18-21(28)2)22-12-14-43(15-13-22)34(45)23-6-7-23)32(25)26(17-20)29-4-3-5-31(42-29)44-33(36(37,38)39)27(19-40-44)35(46)47/h3-5,8,10,16-19,22-23,30,41H,6-7,9,11-15H2,1-2H3,(H,46,47) ODHZMNOWYDDYOX-UHFFFAOYSA-N 431006 US10550102, Example 43 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 23.0 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431006&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627970 438640009 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874832 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)OCC4CC4)c(CC)c3)c12)C(O)=O InChI=1S/C38H42N4O5/c1-3-25-21-28(14-15-29(25)26-17-19-41(20-18-26)38(45)46-23-24-11-12-24)47-34-16-13-27-7-5-8-30(36(27)34)32-9-6-10-35(40-32)42-33(4-2)31(22-39-42)37(43)44/h5-10,14-15,21-22,24,26,34H,3-4,11-13,16-20,23H2,1-2H3,(H,43,44)/t34-/m0/s1 VFPRNERMRDTRGV-UMSFTDKQSA-N 431007 US10550102, Example 64-6 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 1.40 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431007&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 130199863 438640010 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874833 Cc1c(cnn1-c1cccc(c1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H38N4O3/c1-22-19-27(24-15-17-39(18-16-24)35(41)26-9-10-26)12-13-32(22)38-33-14-11-25-5-4-8-30(34(25)33)28-6-3-7-29(20-28)40-23(2)31(21-37-40)36(42)43/h3-8,12-13,19-21,24,26,33,38H,9-11,14-18H2,1-2H3,(H,42,43) MZMWWWTUEBKUJA-UHFFFAOYSA-N 431008 US10550102, Example 44 (+) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431008&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627950 438640011 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874834 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)C(=O)OC)c(CC)c3)c12)C(O)=O InChI=1S/C35H38N4O5/c1-4-22-20-25(13-14-26(22)23-16-18-38(19-17-23)35(42)43-3)44-31-15-12-24-8-6-9-27(33(24)31)29-10-7-11-32(37-29)39-30(5-2)28(21-36-39)34(40)41/h6-11,13-14,20-21,23,31H,4-5,12,15-19H2,1-3H3,(H,40,41)/t31-/m0/s1 OOUNJPIOJOMQAK-HKBQPEDESA-N 431009 US10550102, Example 64-7 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431009&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628137 438640012 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874835 Cc1c(cnn1-c1cccc(c1)-c1cccc2CCC(Nc3ccc(cc3C)C3CCN(CC3)C(=O)C3CC3)c12)C(O)=O InChI=1S/C36H38N4O3/c1-22-19-27(24-15-17-39(18-16-24)35(41)26-9-10-26)12-13-32(22)38-33-14-11-25-5-4-8-30(34(25)33)28-6-3-7-29(20-28)40-23(2)31(21-37-40)36(42)43/h3-8,12-13,19-21,24,26,33,38H,9-11,14-18H2,1-2H3,(H,42,43) MZMWWWTUEBKUJA-UHFFFAOYSA-N 431010 US10550102, Example 44 (-) Guanylate cyclase soluble subunit alpha-1/beta-1 Human 9.90 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431010&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118627950 438640013 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5 874836 CCc1c(cnn1-c1cccc(n1)-c1cccc2CC[C@H](Oc3ccc(C4CCN(CC4)S(C)(=O)=O)c(CC)c3)c12)C(O)=O InChI=1S/C34H38N4O5S/c1-4-22-20-25(13-14-26(22)23-16-18-37(19-17-23)44(3,41)42)43-31-15-12-24-8-6-9-27(33(24)31)29-10-7-11-32(36-29)38-30(5-2)28(21-35-38)34(39)40/h6-11,13-14,20-21,23,31H,4-5,12,15-19H2,1-3H3,(H,39,40)/t31-/m0/s1 PMVXQCJSZKADKT-HKBQPEDESA-N 431011 US10550102, Example 64-8 Guanylate cyclase soluble subunit alpha-1/beta-1 Human 0.500 US Patent 10.7270/Q2PC34SQ aid1804175 US10550102 Adams, CM; Bevan, D; Capparelli, MP; Ehara, T; Ferrara, L; Ji, N; Meredith, E; Mogi, M; Powers, JJ; Prasanna, G; Mainolfi, N; Kato, M 2/4/2020 11/20/2020 NOVARTIS AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=431011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=290&target=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=431011&enzyme=Guanylate+cyclase+soluble+subunit+alpha-1%2Fbeta-1&column=ki&startPg=0&Increment=50&submit=Search 118628106 438640014 2 MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID Guanylate cyclase soluble subunit alpha-1 GCYA1_HUMAN Q02108 D3DP19 D6RDW3 O43843 Q8TAH3 MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD 2WZ1,5MNW,6JT0,6JT1,6JT2,7D9R,7D9S,7D9T,7D9U,8HBE,8HBF,8HBH Guanylate cyclase soluble subunit beta-1 GCYB1_HUMAN Q02153 B7Z426 Q86WY5